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ABSTRACT 
The extent of postpartum negative energy balance in dairy cows is positively 
associated with body condition score (BCS) at calving. Results of epidemiological 
studies have indicated that calving BCS is positively correlated with several 
indicators of immune dysfunction during the post-partum period. Metabolites of 
negative energy balance (NEB) have been associated with impaired lymphocyte 
and neutrophil function in vitro. Therefore, cows that calve in greater condition 
might exhibit a greater degree of periparturient immune dysfunction than thinner 
cows. 
The objective of this thesis was to investigate the effect of BCS at calving on 
adaptive immune function, using in vivo measures. Two experiments were 
conducted using dairy cows in the DairyNZ Lye farm herd. 
The first experiment determined the level of background exposure to Candida 
albicans. Delayed-type hypersensitivity (DTH) to C. albicans is used as an 
indicator of cell-mediated immune response (CMIR) in cattle. Prior immunisation 
against C. albicans ensures measurable DTH responses from most cows. 
However, if natural exposure to C. albicans is high or variable, background DTH 
must be measured before immunisation, or an alternate antigen used. To 
determine background DTH responses in pasture-based cows, responses of ten 
unimmunised and ten immunised cows were compared. A greater proportion of 
immunised versus unimmunised cows mounted a positive DTH response (90% vs. 
70%), and responses were larger (P < 0.01) and more variable (P < 0.05) in 
immunised cows. Results indicate that pasture-based cows in New Zealand have 
consistently low background exposure to C. albicans. Therefore, C. albicans is an 
appropriate antigen for inducing DTH responses as an in vivo measure of CMIR 
in pasture-based cows. 
The second experiment tested the hypothesis that BCS at calving affects immune 
function. The energy balance of sixty healthy cows with similar mid-lactation 
BCS was manipulated in late-lactation to achieve three homogenous BCS groups 
of twenty cows at calving, with calving BCS of 3.4, 4.6 and 5.4 (NZ BCS scale of 
1 to 10). Antibody-mediated immune responses (AMIR) and cell-mediated 
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immune responses (CMIR) measured postpartum were compared with responses 
measured in mid-lactation before BCS manipulation began. Calving BCS had no 
effect on the magnitude of AMIR (P = 0.93) or CMIR (P = 0.99), and did not 
affect the ratio of antigen-specific IgG1 and IgG2 produced during AMIR (P = 
0.48). These results indicate that, within the range of BCS at calving investigated, 
and the associated degree of postpartum NEB did not influence ability to mount 
adaptive immune responses in vivo. 
Cows calving within the BCS range examined (between 3.4 and 5.4) did not differ 
in AMIR or CMIR; therefore, the results support the current recommendations 
regarding optimal calving BCS for mature cows, and support the minimum BCS 
allowed by the welfare code. 
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Chapter 1. General Introduction 
1.1 Introduction 
Dairy farming occurs in nearly every country in the world and supports the 
livelihoods of billions of people, ensuring the on-going sustainability of rural 
communities (The Economic Importance of Dairying, 2013, Schilling et al., 
2010). Globally, milk makes up 8.9% of the value of all agricultural products (The 
Economic Importance of Dairying, 2013). 
 
Figure 1. Contribution of individual primary sectors to total value of New Zealand’s 
primary sector exports in 2009, presented in millions of dollars. Data sourced from 
Schilling et al. (2010). 
The industry is especially important in New Zealand, where milk exports account 
for 26% of agricultural exports (Schilling et al., 2010). Dairy farming contributes 
2.8% of New Zealand‟s GDP, which is over one third of the GDP contribution of 
the entire primary sector (Figure 1; The Economic Importance of Dairying, 2013, 
Schilling et al., 2010). The New Zealand dairy sector directly employs 35,000 
people and indirectly employs many more in businesses that supply the sector 
(Schilling et al., 2010). New Zealand produces only 2% of the world‟s milk but 
exports 95% of this, thereby contributing one third of the total milk products 
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traded internationally (The Economic Importance of Dairying, 2013, Schilling et 
al., 2010). Consequently, New Zealand is particularly vulnerable to changes in 
international demand for milk products and shifts in consumer expectations. 
The dairy industry faces complex demands from consumers. As the global 
population becomes more affluent, demand for milk protein increases. In 
response, dairy producers strive to increase output. The milk production of the 
modern North American dairy cow has doubled in the last 50 years (Oltenacu and 
Broom, 2010) and New Zealand per cow production has increased by at least 50% 
since the mid-seventies (New Zealand Dairy Statistics 2012/13). Unfortunately, 
the increased production has been accompanied by greater incidence of disease 
and arguably decreased welfare for dairy cows (Oltenacu and Broom, 2010). The 
negative effects of high milk production are an area of risk for the dairy industry 
because increased affluence also affords consumers the ability to place greater 
value on animal welfare. Good animal welfare is now synonymous with product 
quality and sustainability (Oltenacu and Broom, 2010).  
In addition to expectations of higher animal welfare, there is increasing public 
pressure to reduce the reliance on antibiotics in food production animals because 
of perceived or potential contribution to antibiotic resistance (Oliver et al., 2011, 
Trevisi et al., 2014). Preventative use of antibiotics is particularly contentious and 
is associated with increased risk of antimicrobial resistance in North America 
(Saini et al., 2013). The incidence of mastitis is lower in New Zealand than in 
overseas dairy industries (Laven and Holmes, 2008) and antibiotic resistance is 
reported to be very low and declining (McDougall et al., 2013). However, our 
customers are influenced by the performance of dairy industries in their own 
country rather than in New Zealand. To maintain our international reputation for 
producing high quality and sustainable milk products, it is essential that the New 
Zealand dairy industry responds to changing consumer expectations. 
The period of greatest risk to the health of the cow and, therefore, to the industry‟s 
animal welfare reputation is during the transition from pregnancy to lactation. 
During the transition period, dairy cows experience profound metabolic changes 
and exhibit a transient immune dysfunction (Drackley, 1999, Mallard et al., 1997). 
Consequently, the incidence of infectious and metabolic disease is high and most 
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antibiotic use in dairy cows is directed toward diseases that occur during early 
lactation. In many New Zealand dairy herds, long acting intra-mammary antibiotic 
therapy is routinely administered to every cow at the end of lactation to prevent 
infection during the early dry period and, therefore, reduce the incidence of 
clinical mastitis during early lactation (Goff and Horst, 1997, Hogeveen et al., 
2011, McDougall et al., 2013). Nevertheless, there is a high incidence of clinical 
mastitis in the first two weeks of lactation (McDougall et al., 2007); so, there is 
considerable reliance on antibiotics to manage mastitis in early lactation. 
Additionally, metritis and endometritis may require treatment with antibiotics and 
both of these diseases have aetiology originating in the transition period. Because 
periparturient immune dysfunction contributes to the high incidence of infectious 
disease in early lactation, selection for increased immune function or management 
strategies that minimise peripartum immune dysfunction might reduce the use of 
antibiotics and improve cow welfare in the dairy industry. 
Management of body condition score at calving may be one way to address the 
early lactation immune dysfunction that leads to the high incidence of disease and 
the reliance on antibiotics. Body condition score, which is a visual assessment of a 
cow‟s energy or fat reserves, is reported to influence cow susceptibility to 
metabolic disease (Bewley and Schutz, 2008, Roche and Berry, 2006, Roche et 
al., 2009) and may also influence immune function (Lacetera et al., 2005, Ohtsuka 
et al., 2008) and, therefore, the risk of infectious disease. However, the 
relationship between body condition at calving and incidence of clinical infectious 
disease is inconsistent (Roche et al., 2009). Body condition score is also regarded 
as an indicator of welfare, in its own right. For example, the New Zealand code of 
welfare for dairy cattle sets a minimum acceptable body condition score (Code of 
Welfare: Dairy Cattle 2014), and most welfare assessment protocols for dairy 
farming include body condition score (De Vries et al., 2011, Matthews et al., 
2012). Thin cows are perceived to suffer reduced welfare; however, the evidence 
in support of this perception is equivocal (Roche et al., 2009). Although thinness 
has been associated with greater morbidity (Gearhart et al., 1990, Hoedemaker et 
al., 2009), these studies were not able to determine whether it was a causal 
relationship or the low BCS was a  consequence of illness-induced weight loss 
(Roche et al., 2009). There is a need for research that directly investigates the 
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relationship between body condition at calving and immune function in early 
lactation, the period of greatest risk in terms of farm profitability, industry 
reputation and cow welfare. 
1.2 Structure of this thesis 
This thesis begins with a review of the literature. Chapter 2 and Chapter 3 provide 
an outline of the bovine immune system and the metabolic and immune changes 
reported to occur as cows transition from gestation to lactation. The relationship 
between body condition and productivity, reproduction and metabolic health is 
described in Chapter 4, before discussing the evidence for a relationship between 
BCS and immune function and what might mediate such a relationship in Chapter 
5. 
Chapter 6 describes a pilot study to establish an in vivo measure of cell-mediated 
immunity, using cows in the pasture-based herd in which the main experiment 
would be conducted. Chapter 7 describes the investigation of adaptive immune 
function in cows with a range of BCS at calving. Salient points arising from these 
experiments, implications for New Zealand dairy farming and direction for future 
research are discussed in concluding Chapter 8. 
Published manuscripts are included in the Appendices. Raw data is provided on a 
DVD inside the back cover of this thesis. 
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Chapter 2. The bovine immune system 
Mammals have evolved a sophisticated immune system to detect and remove or 
neutralise pathogens. The immune system has the ability to distinguish self from 
non-self, and uses an array of specialised cells and molecules to mount fast and 
flexible responses against an almost unlimited array of pathogens. The immune 
system is conceptually divided into two systems illustrated in Figure 2:  
 The innate immune system is present from birth and its mechanisms do not 
evolve with repeated pathogen exposure. It is the “first line of defence”, 
activated immediately after infection (Borghetti et al., 2009). It responds 
to a broad range of pathogens and provides most of the machinery and 
functions needed to fight infection (Mellor and Munn, 2000).  
 The adaptive immune system is largely orchestrated by the action of T-
lymphocytes and B-lymphocytes, which respond to specific antigens and 
develop memory following interaction with antigen, allowing faster 
responses to re-exposure (Mellor and Munn, 2000). 
Innate responses are largely non-specific and are generated quickly upon exposure 
to pathogens. In contrast, adaptive responses are specific but take time to 
generate. These two systems actually co-operate to prevent infection: innate 
responses are enhanced by the adaptive immune system (Roth, 2012) and the 
adaptive system relies on the innate system for activation and initial direction as 
to the nature of response required (Beutler, 2004, Guzman et al., 2012, Mellor and 
Munn, 2000). Cell-to-cell communication, mediated via signalling proteins 
(cytokines) and their cognate surface receptors, allows integration of the two 
systems and controls the type, intensity and duration of responses. In fact, the 
interdependence of the two systems means they can hardly be described as 
separate (Lippolis, 2008). 
  
 
6
 
 
  
Figure 2. The immune system can be conceptually divided into an innate and an adaptive immune system, although there are some cells 
that have features of both systems (source: Dranoff, 2004) 
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2.1 Innate immune system 
The innate immune system uses passive barriers and generalised cell-mediated 
killing mechanisms. It is able to detect common pathogens (e.g. viruses, bacteria, 
fungi, nematodes) by identifying conserved microbial proteins not typically found 
in mammalian cells (e.g. lipopolysaccharide, a protein present on the cell walls of 
all gram-negative bacteria). Such signatures are known as pathogen associated 
molecular patterns (PAMPs) and are recognised by receptors on the cell known as 
pattern recognition receptors (PRRs). Additionally, host cells signal to the 
immune system when damaged or when infected by an intracellular pathogen, 
such as a virus, by releasing cytokines and altering the expression of surface 
molecules. The mechanisms employed in an innate response depend on both the 
type of pathogen and where the pathogen is detected in the body (Figure 3; 
Parham, 2009). Pathogens in extracellular space activate a different combination 
of immune cells and defence mechanisms than do intracellular pathogens. 
 
Figure 3. The innate mechanisms engaged in an immune response are determined by the 
class of pathogen and where it is detected in the body. NK cells = natural killer cells 
(source: figure 2.2, pg. 32, Parham, 2009) 
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 Physical and chemical barriers 2.1.1
The first defences against infection are the physical and chemical barriers afforded 
by the epithelial surfaces of the skin, lungs, mammary glands and the 
gastrointestinal tract (Lippolis, 2008). Sneezing, urination and the production of 
tears assist in flushing contaminants from the body, including harmful pathogens. 
Substances secreted at epithelial barriers in the body, including acids, peptides 
and digestive enzymes (Lippolis, 2008). For example, lysozyme, which is present 
in secretory fluids such as tears, destroys the cell wall of gram-negative and gram-
positive bacteria (Beutler, 2004). Although not strictly a component of the 
immune system, the resident commensal bacterial populations in the gut and on 
skin surfaces also provide protection to the host, by out-competing pathogenic 
bacteria (Kudsk, 2002). Despite these barriers, pathogens sometimes gain entry 
through compromised barriers, such as broken skin, or because they have evolved 
mechanisms specifically to overcome such barriers. 
 Complement system 2.1.2
The complement system consists of a set of proteolytic enzymes, present in high 
concentrations in blood and in tissue, from which a cascade of reactions is 
activated by the presence of extracellular pathogens. Complement proteins work 
in various combinations to coat microbes for phagocytosis, induce inflammation 
and attract neutrophils, form a „membrane attack complexes‟ that can lyse gram-
negative bacteria, and inactivate viruses (Ricklin and Lambris, 2007). Coating of 
microbes (opsonisation) tags them for phagocytosis, which is especially important 
for bacteria with polysaccharide coatings that innate immune cells can‟t otherwise 
attach to for phagocytosis (e.g. Staphlycoccus spp.; Parham, 2009). 
Complement can be activated via three pathways that converge at the cleaving of 
protein C3 (Figure 4; Parham, 2009, Ricklin and Lambris, 2007). The classical 
pathway is initiated when complement component C1 interacts with a microbial 
surface or binds to antibody already bound to pathogen and the lectin pathway is 
initiated through interactions with carbohydrate structures on microbial surface. 
The „alternative‟ pathway is the first pathway activated during infection and can 
be spontaneously activated. Spontaneous hydrolysis of C3 (known as tick-over), 
leads to the formation of C3 convertase which further cleaves C3 molecules and 
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leads to complement activation and deposition of C3b molecules on the microbial 
surface. Complement protein C3b tags the microbe for phagocytosis and is also 
involved in the initial steps of membrane attack complex formation. Complement 
protein C3a acts as a chemoattractant to recruit other immune cells to the site, 
particularly phagocytes. 
 
Figure 4. The three pathways of complement activation converge at the cleaving of C3 to 
C3a and C3b (source: Parham, 2009). 
 Inflammation and the acute phase response 2.1.3
Inflammatory cytokines secreted by macrophages, and other immune cells, act on 
the hypothalamus and peripheral tissues to induce fever, which potentiates 
adaptive immunity and decreases growth and replication of some pathogens. Pro-
inflammatory cytokines also stimulate the liver to increase secretion of positive 
acute phase proteins (APPs) and decrease secretion of negative APPs. For 
example, increased production of C-reactive protein and mannose-binding lectin 
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enhance the binding of complement to bacterial surfaces and increased 
haptoglobin binds free plasma haemoglobin, thereby inhibiting iron uptake by 
microbes. Production of negative APPs such as albumin decreases during an acute 
phase response, possibly to spare protein for the production of positive APPs 
(Cray et al., 2009). Combined induction of fever and the acute phase response are 
aimed at limiting pathogen replication and enhance the innate and adaptive 
immune responses. 
 Cellular defences of the innate system 2.1.4
Cell recruitment 
During infection, cytokines stimulate cells lining the endothelium to express 
adhesion molecules that allow white blood cells to roll along and then adhere to 
the inner surface of the blood vessel where they receive signals to migrate out of 
the blood vessel and travel along a chemokine gradient to the site of inflammation 
(a process known as extravasation; Figure 4). Specific combinations of adhesion 
molecules and chemokines orchestrate recruitment of specific cell types ensuring 
that appropriate immune cells are recruited for the pathogen type and location. 
Phagocytic cells 
Phagocytic cells play a critical role in the innate immunity and include 
neutrophils, monocytes, macrophages and dendritic cells. These cells possess 
PRRs (e.g. toll-like receptor) which recognise:  
 PAMPs: surface-molecule patterns unique to microbes. Most pathogens 
have several types of PAMPs and, therefore, the innate system can 
respond to different classes of pathogen with a suitable, but not finely 
tuned response (Beutler, 2004) 
 Damage-associated molecule patterns (also known as danger-associated 
molecule patterns, DAMPs): molecules normally contained within cells, 
but released during tissue damage (Seong and Matzinger, 2004). 
When PPRs on the surface of phagocytes bind to a PAMP, the phagocyte 
envelopes the pathogen with its cellular membrane, internalising it in a vesicle 
called a phagosome. The fate of the pathogen after phagocytosis depends on the 
class of phagocyte.  
  
1
1
 
 
 
Figure 5. Neutrophils and other white blood cells are recruited to the site of inflammation by obligatory rolling and adhesion, then 
migration out of the blood vessel and chemotaxis along a chemokine gradient (source: McDonald and Kubes, 2011). 
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Neutrophils 
Polymorphonuclear neutrophils are recruited to the site of infection in large 
numbers within hours of pathogen recognition. Neutrophils are short lived and 
only survive in circulation for 1-2 days, before undergoing spontaneous apoptosis. 
Neutrophils once recruited to the site of infection are only capable of one 
phagocytic event; they cannot replenish their granule contents so die by 
undergoing apoptosis and are ingested by macrophages or accumulate as pus. The 
mechanisms by which neutrophils eliminate microbes include phagocytosis-
induced respiratory burst and degranulation, and the formation of neutrophil 
extracellular traps (NETs; Kaplan and Radic, 2012): 
 Phagocytosis induced respiratory burst. After engulfing pathogens, 
neutrophils fuse granules containing microbicidal molecules with the 
phagocytic vesicle, which generates reactive oxygen species (ROS) in the 
vesicle to kill the pathogen. 
 Neutrophil extracellular traps. NETs are constructed of chromatin from 
the nucleus and microbicidal molecules from granules. They are able to 
entrap pathogens that neutrophils are unable to phagocytose; for example, 
Staphylococcus aureus is too hydrophilic for neutrophils to attach to and 
engulf, but is a potent stimulator of NET formation (Kaplan and Radic, 
2012). NETs trap and kill (or contain) bacteria, and also enhance innate 
inflammatory responses.  
The mechanisms neutrophils use to clear infections also damage host tissues, 
particularly the release of reactive oxygen species (ROS); therefore, they are short 
lived and undergo spontaneous apoptosis to limit collateral damage to the host. 
Monocytes, macrophages and dendritic cells 
Monocytes circulate in blood and upon entering tissue mature into long-lived 
macrophages and dendritic cells. Macrophages and dendritic cells can 
phagocytose and kill pathogens using microbicidal agents, but, play an even more 
important role as antigen presenting cells, presenting antigens to cells of the 
adaptive immune system and secreting cytokines that recruit other monocytes and 
neutrophils to the site of infection (Beutler, 2004). Dendritic cells reside in tissues 
that are exposed to the external environment. When they engulf a pathogen, they 
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mature and migrate into the lymph nodes, where they present fragments of the 
pathogen to naïve lymphocytes. Macrophages also reside in tissue, but act more 
locally, presenting antigen to lymphocytes and secreting cytokines that recruit 
other innate immune cells and direct the type of immune response induced. 
Antigen-presenting cells also modulate the adaptive immune system by 
controlling nutrient supply, for example, activated macrophages and dendritic 
cells increase the availability of cysteine to nearby T-lymphocytes (Fox et al., 
2005). Macrophages and dendritic cells are usually the first cells to respond to an 
infection; so, they play an important role in determining the nature of the 
subsequent response. 
Eosinophils, basophils, and mast cells 
Eosinophils, basophils, and mast cells are specialised for destroying large 
extracellular parasites, such as Helminth worms. Eosinophils circulate in blood 
and lymph and are also resident in the lining of the gastrointestinal and 
reproductive tracts. Basophils circulate in blood while mast cells are resident in 
connective tissue and mucosal surfaces. The three cell types often work together; 
mast cells are activated first, which in turn recruit eosinophils and basophils to the 
site of inflammation. When activated, these cells degranulate, releasing 
microbicidal substances into their environment. The granules of mast cells and 
basophils contain histamine and heparin, which increase vascular permeability 
and promote blood flow to the infected tissue. Eosinophils, mast cells and 
basophils have IgE antibody bound to their cell surface, and are activated when 
IgE on their surface is cross-linked by simultaneously binding their cognate 
antigen. This means that they are restricted to responses against multicellular 
pathogens, although they can also be also activated by tissue damage. These cells 
produce cytokines that influence the inflammatory response but also respond to 
cytokines produced by cells of the adaptive immune system (Beutler, 2004). 
Basophils may be particularly important to the establishment of type-2 antibody-
mediated responses because of their ability to produce IL-4 in the initial stages of 
an immune response which promotes type-2 responses (Parham, 2009). 
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Natural killer cells 
Natural killer (NK) cells are specialised cells with the capacity to identify and kill 
infected cells and tumour cells. NK cells destroy cells by inducing apoptosis, 
either by delivering enzymes into the cell via perforin proteins or by binding to 
the Fas protein on the cell surface (Sompayrac, 2012). Natural killer cells have 
features of the innate and the adaptive immune system: the NK cell response is 
modified by repeat exposure to a pathogen (Sun et al., 2010), but they have a 
limited diversity of antigen receptors relative to T-lymphocytes (Sompayrac, 
2012). Like neutrophils, NK cells are „on-call‟ from the blood system. Natural 
killer cells proliferate rapidly at the site of infection and can be activated by 
binding directly to pathogens or in response to interferon cytokines secreted by 
virus infected cells. Interleukin-12 induces NK cells to secrete IFN-γ, which 
primes macrophages to produce more TNF-α and IL-12, which induces NK cells 
to secrete yet more IFN-γ, creating a positive feedback loop. These cells kill 
infected and tumour host cells that express an unusually high ratio of foreign or 
unusual molecules: MHC I on their surface (Sompayrac, 2012), and foreign cells, 
which do not express MHC-I molecules. 
2.2 Cell-to-cell signalling by cytokines 
Cytokines are small proteins, secreted by cells which influence the behaviour of 
other immune cells. There are many different cytokines, some of which are 
outlined in Table 1. They bind to specific receptors on other immune cells, 
influencing their growth, movement and function. A subset of cytokines, called 
chemokines, facilitates the extravasation of immune cells to sites of infection 
(Beutler, 2004). Immune cells are the predominant source of cytokines: however, 
non-immune cells, such as epithelial and adipose cells, also contribute to the 
cytokine milieu during infection or tissue damage (Lippolis, 2008). 
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Table 1. Cell source and actions of prominent cytokines in the bovine immune system. 
Cytokine Cell source Target and action 
IL-2 Macrophages, T-
lymphocytes,  
Natural killer (NK) 
cells 
T- and B-lymphocyte proliferation, 
NK cell activation & proliferation 
IL-8  Macrophages Attracts neutrophils 
Pro-inflammatory cytokines 
TNF-α Macrophages, 
Dendritic cells, T-
lymphocytes 
Activates vascular epithelium facilitating entry 
of complement & immune cells into  tissue 
Neutrophil and NK cell activation, 
Hypothalamus – fever, Liver - acute-phase 
response 
IFN-γ T-lymphocytes,  
Natural killer cells 
Up regulates type-1 cytokine secretion by T-
lymphocytes 
Switches antibody isotype to IgG2 isotype, 
Macrophage, neutrophils and natural killer cell 
activation 
IL-12 Macrophages, 
Dendritic cells 
Polarises T-lymphocyte cytokine secretion 
toward type-1 profile 
NK cell activation 
IL-6 Macrophages Hypothalamus – fever, 
Liver - acute-phase response, 
Promotes type-2 bias by promoting IL-4 
secretion and making CD4+ T-lymphocytes 
unresponsive to IFN-γ  
Anti-inflammatory cytokines 
IL-10 Macrophages,  
T cells 
Inhibits IL-12 production, 
Inhibits Type-1 cytokine production, 
Deactivates natural killer cells 
IL-4 T cells, Mast cells Up regulates Type-2 cytokine secretion by T-
lymphocytes, 
Switches antibody isotype to IgG1 and IgE, 
Inhibits IFN-γ activation of macrophages, 
Down regulates IFN-γ production 
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The first cytokines released during infection are usually pro-inflammatory 
cytokines (e.g., TNF-α and IL-12), which mediate recruitment of immune cells to 
site of infection by inducing expression of adhesion molecules and chemokines on 
the endothelium and also induce maturation of dendritic cells (Lippolis, 2008). 
Later in infection, anti-inflammatory cytokines (e.g., IL-10 and IL-4) start to 
dominate and dampen the inflammatory response, thereby preventing excessive 
damage to the host (Lippolis, 2008). Antigen presentation and cytokine 
production by cells of the innate immune system provides an important link 
between the innate and adaptive immune system (Beutler, 2004). 
2.3 Adaptive immune system 
The adaptive immune response is much slower to develop than the innate 
response. However, the adaptive response is tailored specifically to individual 
pathogens and each time the animal is exposed to the same pathogen, the response 
becomes faster and stronger. Adaptive responses can be broadly divided into two 
types: 
 Cell-mediated immune responses (CMIR), which are commonly 
generated in response to intracellular pathogens and are mediated by T-
lymphocytes.  
 Antibody-mediated immune responses (AMIR), which are commonly 
generated in response to extracellular pathogens and are mediated by B-
lymphocytes. 
T- and B-lymphocytes recognise specific antigens. The fundamental difference 
between T- and B-lymphocytes, apart from their effector mechanisms, is that 
receptors on T-lymphocytes only bind antigens presented to them by other host 
cells, whereas B-lymphocyte receptors bind antigens directly in the extracellular 
environment. The T- or B-lymphocyte receptors on each individual cell can only 
recognise a single specific antigen. Therefore during development, the genes 
encoding these receptors are re-arranged to create millions of different receptors. 
Receptors that are specific for self-antigens are destroyed during maturation. 
Although each lymphocyte is specific for a single antigen, there can be multiple 
lymphocytes which recognise the same antigen. When infected by a new 
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pathogen, each cell with a receptor that recognises the pathogen proliferates to 
produce a clone of thousands of identical cells recognising the same antigen. 
 Immunological Memory 2.3.1
The adaptive immune system acquires memory of pathogens, which facilitate 
much more effective responses to re-invasion. When infection occurs, naïve 
lymphocytes with receptors for an antigen on the pathogen rapidly differentiate 
and proliferate into a small clone of memory cells and a large clone of effector 
cells. Effector cells control the infection, and then undergo apoptosis when the 
infection has cleared. In contrast, memory cells remain in circulation, and can 
immediately differentiate into effector cells on subsequent exposure, allowing a 
more rapid and effective response to re-invasion. 
 T-lymphocytes 2.3.2
Naïve T-lymphocytes are activated by dendritic cells that have migrated into 
lymph nodes after engulfing pathogen. T-lymphocytes can differentiate into two 
sub-populations, as determined by cytokines released by the dendritic cell during 
activation. Each sub-population has distinct functions and is distinguishable by 
cell surface receptors. Receptors on T-lymphocytes are composed of either α and 
β chains or γ and δ chains. T-lymphocytes expressing αβ receptors are the most 
populous and have the largest receptor diversity. In contrast, γδ T-lymphocytes 
straddle the interface of innate and adaptive immune function (Dranoff, 2004) and 
function as regulatory T-lymphocytes in bovines (Guzman et al., 2012). 
αβ T-lymphocytes 
T-lymphocytes with αβ T-lymphocyte receptors recognise antigen fragments 
presented in association with major histocompatibility complex (MHC) molecules 
on the surface of other cells (Beutler, 2004, Lippolis, 2008). There are two types 
of MHC molecule, class I and class II which present different types of antigen and 
have different expression patterns in the body: 
 Intracellular antigens are presented by MHC-I molecules. All cells, except 
red blood cells and platelets, express MHC-I, which display fragments of 
proteins that are being synthesised or degraded within the cell. Foreign 
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protein fragments presented by MHC-I on infected cells invite destruction 
by the immune system.  
 Extracellular pathogens are presented by MHC-II molecules. Only 
specialised antigen presenting cells (i.e. macrophages, dendritic cells, and 
B-lymphocytes) normally express MHC-II. The type of antigen presenting 
cell influences the type of immune response that develops. 
There are two subpopulations of αβ T-lymphocytes, defined by co-receptors that 
bind to either MHC-I or MHC-II. T-lymphocytes with the co-receptor CD4 are 
restricted to antigen presented in complex with MHC-II (Figure 6) and are, 
therefore, specialised to controlling extracellular pathogens. T-lymphocytes with 
the co-receptor CD8 are restricted to antigen presented in complex with MHC-I 
and are, therefore, specialised in control of intracellular pathogens. It should be 
noted however, that CD4+ T-lymphocytes also contribute to control of 
intracellular pathogens when presented antigen by antigen presenting cells 
harbouring microbes in intracellular vesicles. 
 
  Figure 6. Activation of naïve αβ T-lymphocytes.  Cytotoxic T-lymphocytes 
(CTL) express co-receptor CD8, which restricts them to antigen presented in 
MHC-I molecules.  T helper (Th) lymphocytes express co-receptor CD4, which 
restricts them to antigen presented in MHC-II molecules. (source: Sompayrac, 
2012) 
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CD4+ T helper lymphocytes 
T-lymphocytes that express αβ receptors and CD4 co-receptors are known as T-
helper lymphocytes because they help other immune cells to eliminate pathogens, 
rather than killing directly. Naive CD4+ T-lymphocytes are primarily activated by 
dendritic cells but once differentiated, primed T-lymphocytes can be activated by 
any antigen presenting cell. Cytokines secreted by the dendritic cell during 
activation of naïve T-lymphocytes influence the cytokines expressed by that T-
lymphocyte once mature (Lippolis, 2008). There are several discrete 
subpopulations of CD4+ T-lymphocytes described in mice, including TH1, TH2, 
TH17, and Trig & TFH, each with a signature cytokine expression profile. In 
bovines, the same discrete subpopulations are not present; but rather the cytokine 
expression profiles of bovine CD4+ T-lymphocytes exist on a spectrum and 
secrete a range of cytokines (Brown et al., 1998). However, polarised responses to 
different types of antigens do occur in cattle and CD4+ cells in this species can be 
described in terms of polarised rather than discrete subpopulations. In mice, each 
subpopulation secretes a different combination of cytokines to direct immune 
responses, as illustrated in Figure 7 (Lippolis, 2008).  
TH1 – drives cell-mediated immunity 
TH1 lymphocytes secrete IFN-γ to activate adjacent macrophages and 
enhance killing of phagocytosed pathogens by macrophages. Interferon-γ 
inhibits IL-4 secretion by other T-lymphocytes. They also stimulate and 
enhance the cytotoxic activity of CD8+ T-lymphocytes. The IFN-γ 
mediated response is associated with inflammation. TH1 cells are the 
principal regulators of type-1 (cell-mediated) responses aimed at 
eliminating intracellular pathogens. 
TH2 – drives antibody-mediated immunity 
TH2 cells secrete IL-4 to stimulate naïve B-lymphocyte proliferation and 
differentiation to antibody secreting cells and memory cells. Interleukin-4 
also inhibits IFN-γ secretion by other T-lymphocytes and macrophages. 
TH2 lymphocytes are the principal regulators of type-2 (antibody-
mediated) responses aimed at eliminating extracellular pathogens. 
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Figure 7. Dendritic cells secrete cytokines during activation of naïve T-lymphocytes, 
which influence the cytokine expression profile of the resulting mature T-lymphocytes. 
In this illustration, activation of naïve T-helper lymphocytes in the presence of IL-12 
produces mature T-helper (Th) cells that tend to secrete more IFN-γ than other 
cytokines. IFN = interferon; IL = interleukin. (Modified from: Lippolis, 2008) 
CD8+ Cytotoxic T-lymphocytes 
T-lymphocytes that express the CD8 co-presentation molecule are known as 
CD8+ or cytotoxic T-lymphocytes. After activation, CD8+ T-lymphocytes 
migrate to the site of infection and destroy cells displaying their cognate antigen 
in complex with MHC-I. Killing of infected cells is achieved by secretion of 
perforin, which makes a hole in the cell membrane, through which secretion of 
another protein induces apoptosis of the cell. Their function is similar to that of 
NK cells, in that they are specialised in destroying virus infected cells, before the 
virus is able to replicate and leave the cell. However, CD8+ T-lymphocytes are 
able to identify infected cells that still have normal MHC-I expression, which NK 
cells cannot. Like CD4+ T-lymphocytes, CD8+ T-lymphocytes secrete cytokines 
to regulate the immune response; cells that secrete IFN-γ stimulate macrophages 
and NK cells, whereas cells that secrete IL-4 and IL-10 inhibit macrophage and 
NK cell activity. CD8+ T-lymphocytes contribute to escalation, and then 
regulation of responses against intracellular infections. 
 21 
 
Regulatory γδ T-lymphocytes 
T-lymphocytes with γδ T-lymphocyte receptors play an important role in T-
lymphocyte regulation in the bovine (Coussens et al., 2012, Hoek et al., 2009); 
they contribute to both the establishment and resolution of the immune response 
(Bailey et al., 2013). In contrast to most other mammals, a large proportion of 
circulating T-lymphocytes in cattle are γδ T-lymphocytes, especially in calves, 
and the γδ receptor repertoire is much more diverse (Bailey et al., 2013, Guzman 
et al., 2012). They are not restricted by MHC-I or MHC-II; therefore, naïve γδ T-
lymphocytes do not rely on antigen presenting cells for activation; in fact, they are 
able to present antigen in MHC-II complex to CD4+ T-lymphocytes (Guzman et 
al., 2012). They appear to be involved in responses against intracellular 
pathogens, such as Johne‟s (Mycobacterium paratuberculosis); (Plattner et al., 
2014). They can secrete pro-inflammatory cytokines (TNF-α and IFN-γ) and anti-
inflammatory cytokines (IL-10); their rapid response at the start of infection 
supports development of the adaptive immune response, but, as infection 
progresses, the γδ T-lymphocyte population takes on a regulatory role (Coussens 
et al., 2012, Plattner et al., 2014). 
 B-lymphocytes 2.3.3
The B-cell receptor on B-lymphocytes is composed of a transmembrane 
immunoglobulin molecule. The basis of antibody-mediated immune responses is 
antibodies secreted by plasma B-lymphocytes. The help of CD4+ T-lymphocytes 
is required for antibody production against most pathogens and this help occurs in 
the secondary lymphoid organs where IL-4-expressing CD4+ T-lymphocytes 
accumulate. When a naïve B-lymphocyte‟s receptor binds to its cognate antigen 
on the surface of a pathogen, it engulfs the pathogen and presents antigen 
fragments in complex with MHC-II on its surface. This activates T-lymphocytes 
with a receptor for the same antigen fragment to secrete cytokines that trigger B-
lymphocyte proliferation and differentiation into plasma cells, capable of 
producing copious amounts of antibody specific for the original antigen. 
Antibodies are selectively transported from blood to the extracellular fluid, where 
they opsonise extracellular pathogens for removal or killing by phagocytes, 
activate the complement cascade, and coat toxins and viruses to neutralise them. 
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Figure 8. The first antibody response to antigen exposure (the primary response) is 
small; however, the memory lymphocytes generated during initial antigen exposure 
remain in circulation for a long time and allow a much faster and more specific 
secondary antibody response to subsequent antigen exposure. 
Antibody isotypes and switching 
As an antibody-mediated immune response progresses, the affinity of the secreted 
antibody for its cognate antigen improves as a consequence of somatic hyper 
mutation leading to affinity maturation of the antibody population. Clonal 
expansion of the naïve B-lymphocyte occurs in two phases. In the initial phase, 
the plasma cells produced secrete mostly IgM, which tags the pathogen and 
activates complement. Later in the response, the cytokine milieu signals the 
plasma cells to switch to secreting antibody isotypes more suited to the target 
(Figure 8; Heriazon et al., 2011). This switch occurs during primary and 
secondary antibody responses, except that during secondary responses, memory 
B-lymphocytes proliferate into plasma cells that are already isotype switched; so, 
large amounts of the appropriate isotype are quickly produced. Isotype switching 
produces isotypes with different effector functions and is critical to the 
establishment of type-1 and type-2 responses (Begley et al., 2009a).  
The isotypes differ in their „constant‟ region, the shape of which determines how 
flexible the antibody structure is and what effector functions they can engage:  
 IgG is the most abundant isotype in body fluids, present in lymph, serum 
and milk, and is essential for combating systemic disease. It is smaller and 
more flexible than IgM, which affords it better access to antigens in small 
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spaces. There are two main subtypes of IgG, with IgG1 usually more 
abundant than IgG2, especially in colostrum as a consequence of IgG1 
being selectively transported from circulation into the mammary gland 
during colostrogenesis (Butler et al., 1971). IgG1 and IgG2 both contribute 
to responses against extracellular and intracellular pathogens (Heriazon et 
al., 2011); however IgG1 is more efficient at fixing complement (McGuire 
et al., 1979). In contrast, bovine IgG2 does not require complement 
fixation for potent opsonin activity and is considered the main opsonin 
supporting neutrophil phagocytosis in the mammary gland (Atalla et al., 
2010, Guidry, 1993). IgG2 is considered a type-1 because it supports 
inflammatory mechanisms; whereas, IgG1 production is considered more 
a type-2 reaction because type-2 cytokines induce IgG1 production (Estes 
and Brown, 2002). 
 IgA is also produced by plasma cells in lymph tissue near mucosal 
surfaces, such as in the gut and respiratory tract, and in exocrine glands 
secretions, such as tears (Butler et al., 1971), where it binds extracellular 
pathogens and toxins (Parham, 2009). 
 IgE binds with very high affinity to eosinophils, mast cells and basophils 
and is essential to activating their degranulation during parasitic infections. 
2.4 Response type 
Antibody-mediated and cell-mediated immune responses are not mutually 
exclusive; during any adaptive response, both responses will be present. The 
combination of innate and adaptive functions engaged in an immune response 
tends to polarise reactions towards one of two types of response depending on the 
pathogen encountered. Each responses being defined by the innate mechanisms at 
play, cytokine environment established and antibody isotypes produced: 
Type-1 
Cytokines produced by TH1 lymphocytes promotes type-1 or CMIR against 
intracellular pathogens. Type-1 responses are characterised by intense 
phagocytic activity by cytotoxic CD8 cells, NK cells and macrophages, 
mediated by production of pro-inflammatory cytokines (IFN-y, TNF-a, IL-
12), and enhanced B-lymphocyte production of antibodies, including IgG2 
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in cattle which act as opsonins (Estes and Brown, 2002, Estes et al., 1994, 
Goldszmid and Trinchieri, 2012, Heriazon et al., 2011) 
Type-2 
Cytokines produced by TH2 lymphocytes promote type-2 or AMIR against 
extracellular pathogens. Type-2 responses are characterised by the 
production of antibody, mediated by the production of anti-inflammatory 
cytokines (IL-4, IL-6, IL-10), which enhance B-lymphocyte production of 
IgG1 and suppress macrophage IFN-γ secretion and deactivate neutrophils 
(Dosogne et al., 1999, Estes and Brown, 2002, Estes et al., 1995, 
Goldszmid and Trinchieri, 2012). 
Cytokines involved in each type of reaction tend to inhibit or modulate the action 
of cytokines produced in the other type of reaction. Therefore adaptive immune 
responses may be polarised towards CMIR (type 1) or AMIR (type2), depending 
on the antigen. In cattle, polarisation of the response can be assessed by looking at 
the ratio of IgG1:IgG2 and the ratio of IL-4:IFN-γ produced during a response 
(Heriazon et al., 2011, Hine et al., 2011). A balanced ability to mount both type-1 
and type-2 responses is important for control of intra- and extra-cellular 
pathogens. Responses that are initially type-1 in nature are followed by a shift to 
type-2 mechanisms, which resolve the response by promoting AMIR and 
suppressing CMIR (Spellberg and Edwards, 2001). 
2.5 Costs of immunity 
Maintaining a responsive immune system does not come without cost. A constant 
supply of protein and energy is needed to maintain the cell populations and 
physical barriers of the immune system (Beisel, 1977, Calder, 1995, 2006, Healy 
et al., 2002, Kim et al., 2007, Lochmiller and Deerenberg, 2000, Newsholme et 
al., 1999, Scrimshaw and SanGiovanni, 1997). For example, about 1 billion 
replacement neutrophils are generated per kilogram of body weight (BWT) per 
day (Dancey et al., 1976). To mount an active immune response further increases 
protein and energy requirements (Fox et al., 2005, Kominsky et al., 2010, MacIver 
et al., 2008, Matarese and La Cava, 2004), for synthesis of antibodies, cytokines, 
complement and acute phase proteins (Li et al., 2007), and for cell structures and 
enzymes of proliferating cells (Beisel, 1977). Initiating an immune response is 
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reported to increase energy requirements by 25-60% of basal metabolic 
requirements (Demas, 2004, Straub et al., 2010). 
Each immune response also incurs costs in terms of collateral damage. An 
inflammatory response always incurs some tissue damage to the host (Goldszmid 
and Trinchieri, 2012). During inflammation, ROS and RNS are produced by 
immune cells to kill pathogens, but the oxidants are not selective and affect host 
cells as well. Additionally, an excessive or unresolved response can lead to 
systemic inflammation, changes in metabolism, and impaired response to other 
infections (Goldszmid and Trinchieri, 2012). Finally, the adaptive immune system 
sometimes responds inappropriately to harmless antigens, as in allergies, and can 
direct effector mechanisms toward host cells, as in auto-immune diseases. 
However, although immune responses have a high cost in terms of collateral 
damage and partitioning of nutrients away from production, production losses due 
to occurrence of disease in animals with less than optimal immune responsiveness 
may outweigh those losses (Colditz, 2008). 
2.6 Summary of the immune system 
The immune system comprises an innate system, which immediately mounts an 
immune response to pathogens upon initial exposure and is largely non-specific in 
its nature, and an adaptive system, which takes time to develop, but produces a 
response that is highly specific to the invading pathogen and results in 
immunological memory. The two systems synergise via intricate cell-to-cell 
communication, using cytokines, adhesion molecules and cell receptors; this 
integration enhances the innate response and is essential to the development of the 
adaptive response. Adaptive immune responses can be broadly classified as type-1 
(CMIR) and type-2 (AMIR), which are largely directed at intracellular and 
extracellular pathogens, respectively. Competent immune function depends on a 
fine balance between effector and regulatory mechanisms to ensure efficient 
pathogen clearance, while limiting collateral damage; any imbalance can lead to 
either chronic infection or chronic inflammation (Hoek et al., 2009). 
(Parham, 2009, Roth, 2012, Sompayrac, 2012)  
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Chapter 3. The transition period and 
immune suppression 
3.1 What is the transition period? 
The „transition period‟, defined as three weeks before calving to three weeks after 
calving, is a significant metabolic challenge for the dairy cow, due to dramatic 
changes in nutrient demands and sinks (Bell, 1995, Drackley, 1999, Goff, 2006, 
Moyes et al., 2010, Roche et al., 2013a, Roche et al., 2009). Failure to transition 
successfully is believed to affect individual cow‟s productivity and disease 
susceptibility (Drackley, 1999, Roche et al., 2013a). Consistent with this view, 
Godden et al. (2003) reported that 25% of cows culled in dairy herds, in 
Minnesota, left the herd in the first 60 DIM. The onset of most metabolic diseases 
occurs within the first two weeks postpartum, and the incidence of infectious 
disease is highest during this period (Goff and Horst, 1997). Disease occurrence 
during the transition period impacts productivity beyond the period of clinical 
symptoms (Bar et al., 2007, Fetrow et al., 1991, Wilson et al., 2008) and may also 
have a negative effect on a cow‟s subsequent reproductive success (Roche et al., 
2009, Staples et al., 1990, Wilson et al., 2008). Therefore, successful navigation 
of the transition from gestation to lactation is of high importance to dairy farming 
profitability (Drackley, 1999, Grummer, 1995). 
A fully functioning immune system is essential for protection from infection in 
the mammary gland during lactation and for remodelling the uterus after 
parturition. A competent immune system also supports immunity in the 
immunologically-naïve new-born calf through the passive transfer of maternal 
antibodies via colostrum. And yet, during the transition from pregnancy to 
lactation, dairy cows exhibit a profound immune dysfunction, which contributes 
to higher incidence of mastitis and the clinical manifestation of many diseases 
during the early post-partum period. 
3.2 Peripartum immune dysfunction 
Hormonal and metabolic changes during the transition period lead to impaired 
immune function which negatively impacts on the ability of the immune system to 
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fight infections. Dairy cows exhibit a transient type-2 shift in immune function 
during gestation (Hine et al., 2011, Maeda et al., 2013) and the transition to 
lactation that is common to mammals (Goff, 2006, Kehrli et al., 2006, Mallard et 
al., 1997, Mellor and Munn, 2000, Schwarm et al., 2013, Shafer-Weaver et al., 
1999, Trowsdale and Betz, 2006). Suppression of type-1 cellular immune 
responses during pregnancy is thought to prevent rejection of the conceptus, 
which expresses non-maternal antigens (Kehrli Jr and Harp, 2001, Maeda et al., 
2013, Mellor and Munn, 2000, Trowsdale and Betz, 2006) and to minimise 
unwanted immune responses against self- and fetal-antigens exposed as a result of 
tissue damage during parturition (Kehrli Jr and Harp, 2001). Up-regulation of 
type-2 functions may also support production of IgG1 for transport to colostrum, 
which is especially important for ruminants because there is no placental transfer 
of maternal antibodies and the ability of the neonate to absorb antibody through 
the gut wall declines rapidly after birth (Quigley and Drewry, 1998, Shafer-
Weaver et al., 1999). Although suppression of type-1 immunity is typical for 
gestating mammals and helps prevent harmful immune responses, the changes 
that occur in dairy cows during the periparturient period are more profound and 
extend further beyond parturition (Mallard et al., 1998, Theodorou et al., 2007). 
Changes are apparent in both the innate and adaptive arms of immunity, normally 
from about 3 weeks before parturition to 3 weeks after parturition with most 
severe immune dysfunction being observed at parturition, though the timing 
depends on the immune function measured (Mallard et al., 1998). This immune 
dysfunction contributes to the high incidence of clinical infectious disease 
observed during the periparturient period (Burvenich et al., 2007, Drackley, 1999, 
Mallard et al., 1998, Smith et al., 1985). 
3.3 Lactation contributes to immune suppression 
Many of the changes in immune function postpartum are attributable to the 
presence of the mammary gland and lactation (Kimura et al., 1999, Kimura et al., 
2002, Nonnecke et al., 2003). A series of experiments by Kimura, Nonnecke and 
Goff et al. (Goff et al., 2002, Kimura et al., 1998, 1999, 2002, Nonnecke et al., 
2003) studied neutrophil and lymphocyte function in cows that were 
mastectomised, compared with cows that were intact, during the transition period. 
In mastectomised cows, most immune functions returned to normal approximately 
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one week after parturition. In contrast, immune dysfunction of intact cows was not 
resolved until several weeks after parturition. The ability of neutrophils to kill 
ingested bacteria (as indicated by myeloperoxidase activity) decreased before 
parturition in both intact and mastectomised cows, but was quickly recovered in 
mastectomised cows; in comparison, intact cows continued to have depressed 
neutrophil function for at least three weeks (Figure 9; Kimura et al., 1999). 
Mastectomised cows did not exhibit the same changes in peripheral blood 
immune cell populations, even before parturition (Figure 10; Kimura et al., 2002), 
and their lymphocyte functions (proliferation, IFN- secretion, and T-lymphocyte 
dependent IgM secretion) were not suppressed to the same extent (Nonnecke et 
al., 2003). These studies demonstrated that, although a degree of immune 
suppression was evident as a result of parturition, the demands of lactation may be 
responsible for the delayed recovery of normal immune function postpartum 
(Goff, 2006, Kimura et al., 1999). 
 
Figure 9. Ability of neutrophils to kill ingested bacteria, indicated by Myeloperoxidase 
activity, in mastectomised cows (n = 10, ◘) and intact cows (n = 8,solid line ●), during the 
periparturient period (mean ± SEM; sourced from Kimura et al., 1999). 
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 Metabolic stress 3.3.1
Lactation, in dairy cows, contributes to extended immune dysfunction for several 
weeks postpartum probably because it induces metabolic stress. Metabolic stress 
occurs when an imbalance between nutrient demand and nutrient intake forces 
some metabolic processes to be compromised or down-regulated. During the 
transition from pregnancy to lactation, a dramatic increase in nutrient 
requirements (for milk production) causes metabolic stress because nutrient intake 
does not increase as quickly (Roche et al., 2009). Additionally, changes in the 
concentration of circulating hormones, and tissue sensitivity to hormones, skew 
the partitioning of nutrients to the mammary gland, further exacerbating metabolic 
stress in the rest of the cow. Cows that exhibit greater metabolic stress during 
transition, indicated by more negative energy balance postpartum, have increased 
systemic inflammation and oxidative stress, and poorer neutrophil function than 
cows with less negative postpartum energy balance (Graugnard et al., 2012). 
Figure 10. Percentage of total T-lymphocytes (a), T-helper lymphocytes (b), T-cytotoxic 
cells (c), and gamma-delta T-lymphocytes (d) in peripheral whole blood from intact (n = 
8, solid line ●) and mastectomised cows (n = 10, ◘) during the periparturient period 
(mean ± SEM; sourced from Kimura et al., 2002) 
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3.4 Changes to the innate immune system around 
calving 
 Monocytes 3.4.1
Changes in the monocyte population are thought to contribute to the increased 
inflammatory state observed in periparturient dairy cows. The proportion of 
monocytes in blood is increased during the periparturient period (Kimura et al., 
2002, Park et al., 1992, Shafer-Weaver et al., 1999, Shafer-Weaver and Sordillo, 
1997). Additionally, monocytes isolated from blood and the supramammary 
lymph nodes of periparturient cows secrete more TNF-α when stimulated with 
lipopolysaccharide, than those from mid-lactation cows (Sordillo et al., 1995). 
Monocyte secretion of TNF-α in response to antigen exposure usually induces 
inflammatory, cell-mediated immune responses by activating and recruiting 
neutrophils. On this basis it is thought that monocytes exacerbate inflammation in 
periparturient cows. 
 Neutrophils 3.4.2
There are changes in both number and effector functions of neutrophils during the 
peripartum period (depicted in Figure 11). Blood neutrophil count increases from 
Figure 11. A stylised representation of the changes that occur in the peripheral 
blood neutrophil population of dairy cows during the periparturient period.  
The normal number of mature neutrophils is 25 times the normal number of 
immature neutrophils.  NETs = neutrophil extracellular traps; ROS = reactive 
oxygen species. 
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about five weeks pre-calving, then declines to normal levels in the first week of 
lactation (Detilleux et al., 1995, Gilbert et al., 1993). In the second week of 
lactation, large numbers of immature neutrophils enter circulation (Detilleux et 
al., 1995). Neutrophil expression of NETs increases pre-partum and then 
decreases (Revelo and Waldron, 2010), in line with the maturity of the neutrophil 
population; immature neutrophils do not produce NETs (Lukášová et al., 2013). 
Phagocytic ability is generally increased around parturition, although not for all 
pathogens (Detilleux et al., 1995, Dosogne et al., 1999, Revelo and Waldron, 
2010, Saad et al., 1989). In contrast, neutrophil capacity to generate intracellular 
and extracellular ROS is reduced in the first three weeks postpartum (Detilleux et 
al., 1995, Dosogne et al., 1999, Revelo and Waldron, 2010) and does not reflect 
population changes. Reduced expression of adhesion molecules and chemo-
attractant receptors also renders neutrophils less able to leave circulation and enter 
tissue, delaying recruitment to the site of infection (Heyneman et al., 1990, Hill, 
1981, Kehrli et al., 1999, Kehrli et al., 2006, Seo et al., 2013). Consequently, 
despite increased TNF-α secretion by periparturient macrophages, the ability of 
neutrophils to migrate to the site of infection and eliminate pathogens is impaired 
in early lactation (Detilleux et al., 1995, Kehrli et al., 2006). 
Increased impairment of neutrophil function during the periparturient period is 
associated with increased incidence of retained foetal membranes and uterine 
infections (Cai et al., 1994, Gunnink, 1984) and with increased incidence and 
severity of mastitis (Heyneman et al., 1990, Hill, 1981, Kremer et al., 1993, 
Mehrzad et al., 2005, Shuster et al., 1996, Zecconi et al., 1994). Delayed 
neutrophil recruitment and impaired oxygen-dependent killing contributes to an 
increase in the incidence and severity of infection in periparturient cows and as a 
consequence compromises innate immune system function and subsequent 
initiation of an appropriate adaptive response. 
3.5 Changes to the adaptive immune system 
around calving 
Adaptive immune function is altered around calving, with changes apparent in 
both the B- and T-lymphocyte populations during the periparturient period. 
Peripheral blood lymphocyte and milk lymphocyte blastogenesis and proliferation 
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in response to stimulation with mitogens decrease in the first week following 
parturition (Kehrli Jr et al., 1989, Nonnecke et al., 2003, Saad et al., 1989, Wells 
et al., 1977). Blood lymphocyte responsiveness recovers within two weeks of 
parturition, whereas milk lymphocyte responsiveness remains low for several 
weeks (Saad et al., 1989). Changes are more evident and broader in scope in the 
T-lymphocyte population whose effector function is biased away from type-1 
inflammatory responses. 
 T-lymphocytes 3.5.1
There are major changes in the T-lymphocyte population during the periparturient 
period which result in suppression of type-1 responses in favour of type-2 
responses. Numbers of T-lymphocytes in blood (irrespective of type) are reduced 
for about two weeks before and after parturition, with nadir at parturition (Kehrli 
et al., 2006, Kimura et al., 2002, Shafer-Weaver et al., 1999, Shafer-Weaver and 
Sordillo, 1997). Similarly, the percentage of T-lymphocytes in milk during the 
postpartum period is a quarter of the percentage present in mid-lactation (Park et 
al., 1992). The ratio of CD4:CD8 is lower in blood and milk and a higher 
proportion of the CD8+ T-lymphocytes are activated and of the suppressor rather 
than cytotoxic phenotype (Kehrli et al., 2006, Shafer-Weaver and Sordillo, 1997). 
The percentage of γδ T-lymphocytes decreases postpartum, although the 
magnitude of the decrease is not always significant (Kimura et al., 2002, Shafer-
Weaver et al., 1999), so it is likely that the differences in cytokine expression of 
peripartum T-lymphocytes is the influence of suppressive CD8+ T-lymphocytes 
rather than γδ T-lymphocytes (Shafer-Weaver et al., 1999). Suppressor CD8+ T-
lymphocytes secrete IL-4, which upregulates the expression of type-2 cytokines 
and downregulates the expression of type-1 cytokines by CD4+ T-lymphocytes 
(Brown et al., 1998, Shafer-Weaver et al., 1999, Shafer-Weaver and Sordillo, 
1997). Consequently, the cytokine expression profile of CD4+ and CD8+ T-
lymphocytes is type-2 biased, secreting less IL-2 and IFN-γ and more IL-4 and 
IL-10 during the periparturient period as compared with mid lactation (Shafer-
Weaver et al., 1999, Shafer-Weaver and Sordillo, 1997). Interferon-γ is the central 
cytokine in development of CMIR (Young and Hardy, 1995); therefore, 
periparturient T-lymphocytes are less able to mount strong cell-mediated 
responses when required.  
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 B lymphocytes 3.5.2
During the peripartum period, B-lymphocyte responses are suppressed, despite a 
supportive type-2 cytokine milieu secreted by T-lymphocytes. The capacity for 
antibody-mediated immune responses decreases for a short period around 
parturition but returns to normal within the first two weeks of lactation. The 
percentage of B-lymphocytes in blood tends to decline at calving (Kimura et al., 
2002, Mallard et al., 1998, Nagahata et al., 1992, Shafer-Weaver et al., 1999), 
whereas the population of B-lymphocytes in milk is increased (Park et al., 1992). 
In vitro B-lymphocyte proliferation and antibody secretion decline several weeks 
pre-calving and are lowest immediately after calving, then recover within the first 
two weeks of lactation (Detilleux et al., 1995, Ishikawa, 1987, Nagahata et al., 
1992, Nonnecke et al., 2003, Sasaki et al., 1976, Stabel et al., 1991). In the two 
weeks pre-partum, IgG1 is selectively transported from the blood circulation and 
is present in colostrum at a much higher ratio of IgG1:IgG2 than that in blood 
(Sasaki et al., 1976). Unlike IgG1, serum IgG2 concentration increases in the 
week before parturition (Detilleux et al. (1995) and remains elevated during early 
lactation (Mallard et al., 1983). It is well documented that IgG1 is selectively 
transferred to colostrum and that IgG2 only enters the mammary gland in 
significant quantities during infection (Mallard et al., 1983, Sasaki et al., 1976).  
Overall, the changes observed in the B-lymphocyte population reflect a 
generalised suppression and a type-2 shift in immune response bias. 
3.6 Infectious disease 
Due to periparturient immune dysfunction, the incidence of clinical infectious 
disease is highest during early lactation. The periparturient udder is particularly 
susceptible to new infections and many subclinical intramammary infections 
progress to clinical mastitis during early lactation (Goff and Horst, 1997, Kehrli et 
al., 2006, Oliver and Sordillo, 1988, Smith et al., 1985). At least 25-50% of 
clinical mastitis occurs in the first month after calving (Loker et al., 2012, 
McDougall et al., 2007, Miltenburg et al., 1996) and, the severity of new 
intramammary infections is greater in the periparturient period than at other stages 
of lactation. For example, Escherichia coliform infections are less likely to self-
cure without antibiotic during the periparturient period (Hill, 1981, Shuster et al., 
1996, Vangroenweghe et al., 2005). Additionally, many other infectious diseases 
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that the immune system had previously been able to control become clinically 
apparent during the first two weeks of lactation (Kehrli et al., 2006). For example, 
clinical manifestation of Johne‟s (Mycobacterium paratuberculosis) usually 
occurs during the periparturient period (Stabel and Goff, 2004, Stabel et al., 2003) 
and immunity to gastrointestinal nematodes is also suppressed (Barger and Gibbs, 
1981, Houdijk, 2008, Kloosterman et al., 1985). The increased incidence and 
severity of infection indicates a reduced ability to resist new infection and to 
continue to contain latent subclinical infections during the periparturient period. 
 Infectious disease is associated with immune dysfunction 3.6.1
Although periparturient immune dysfunction has been reported in all dairy 
systems (Detilleux et al., 1995), not all cows exhibit periparturient immune 
dysfunction. Mallard et al. (1997) and Wagter et al. (2000) reported that one third 
of cows did not exhibit depressed AMIR postpartum; these cows had lower 
incidence of disease, especially mastitis, higher response to J5 E. coli vaccination, 
and lower somatic cell count, than cows with depressed AMIR (Mallard et al., 
1997, Wagter et al., 2000), indicating that AMIR may contribute to defence of the 
mammary gland. 
The adaptive CMIR is also critical to periparturient health. A competent type-1 
response is required to control Johne‟s, Theileria spp and the small colony variant 
form of Staphylococcus aureus (Atalla et al., 2010, Grönlund et al., 2006, Katzer 
et al., 2007, McKeever et al., 1994, Plattner and Hostetter, 2011). For example, 
progression from subclinical to clinical M. paratuberculosis is associated with a 
switch from inflammatory and cytotoxic type-1 response to a type-2 response 
(Coussens et al., 2012, Plattner and Hostetter, 2011). The bias towards type-2 
responses post-calving may contribute to increased clinical manifestation of 
diseases best controlled by type-1 responses in early lactation.  
3.7 Summary of immune dysfunction in the 
transition period 
During the periparturient period, both innate and adaptive immune defences 
become dysfunctional, resulting in inefficient pathogen clearance. The overriding 
feature of bovine peripartum immunity is suppression of inflammatory responses 
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and bias of T-lymphocytes toward a type-2 cytokine profile immediately after 
calving (Kehrli et al., 2006, Shafer-Weaver et al., 1999). The type-2 bias may 
prevent unwanted immune responses toward self- and fetal-antigens (Kehrli Jr and 
Harp, 2001) and support production of maternal antibody for transport into 
colostrum (Shafer-Weaver et al., 1999). Type-2 bias may also limit the impact of 
excessive pro-inflammatory cytokine secretion by monocytes and macrophages 
postpartum (Shafer-Weaver et al., 1999). However, in the absence of enhanced by 
type-1 cytokine production, the innate immune system operates at a reduced 
capacity, leading to increased incidence and severity of clinical infections. 
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Chapter 4. Body Condition Score 
4.1 Assessment of energy reserves. 
 Anatomy considered in body condition score assessment 4.1.1
Body condition score (BCS) is a subjective assessment of an animal‟s energy 
reserves, based on a visual and/or tactile assessment of subcutaneous fat deposits 
(Bewley and Schutz, 2008, Roche et al., 2009). The anatomy considered most 
important include the thoracic and vertebral region of the spinal column (chine, 
loin and rump), the ribs, the spinous processes (loin), the tuber sacrale (hip or 
hook bones), the tuber ischii (pin bones), the anterior coccygeal vertebrae (tail 
head) and the thigh region (Figure 12., Earle, 1976, Macdonald and Roche, 2004, 
Wildman et al., 1982). 
 
Figure 12. The eight points of anatomy considered when assessing body condition score 
using the New Zealand system (source: DairyNZ body condition scoring: The reference 
guide for New Zealand dairy farmers, 2012). This cow has a BCS of 4.0 on a scale of 1 to 
10. 
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 International Body condition score systems 4.1.2
Multiple BCS systems have evolved around the world; however, common to all 
scales is that low values represent emaciation and high values represent obesity 
(Bewley and Schutz, 2008, Roche et al., 2009). The systems‟ vary in their reliance 
on visual versus tactile assessment, and there are subtle differences in the 
emphasis placed on the different body parts considered during assessment 
(Bewley and Schutz, 2008, Roche et al., 2009) . Assessments can be converted 
between scales, allowing comparison of international results (Bewley et al., 2010, 
Roche et al., 2004). All BCS in this thesis will be presented using the New 
Zealand scale of 1 to 10 (Macdonald and Roche, 2011), on which, scores below 
3.0 reflect emaciation and those above 6.0 are considered obese. Body condition 
scores originally reported using different BCS scales are converted to the New 
Zealand scale using the equations of Roche et al. (2004). 
 Accuracy of body condition score systems 4.1.3
The systems of BCS were developed because of recognition that changes in body 
weight (BWT) didn‟t adequately reflect changes in stores of fat and protein 
(Bewley and Schutz, 2008, Roche et al., 2009). Cows of a specific BWT may be 
tall and thin or short and fat, and within cow, BWT is highly variable due to gut 
fill and changing pregnancy status (Bewley and Schutz, 2008). Andrew et al. 
(1994) and Gibb et al. (1992) reported that energy stores varied by as much as 
40% in cows of similar BW, highlighting the futility and inaccuracy of relying on 
BWT alone as an index of cow condition.  
In comparison, dissection studies have reported that BCS is correlated with total 
body fat (Waltner et al., 1994, Wright and Russel, 1984), internal fat and dissected 
fat (Gregory et al., 1998, Otto et al., 1991), ultrasound subcutaneous fat thickness 
(Bewley and Schutz, 2008, Domecq et al., 1995, Hussein et al., 2013), and the 
muscle to bone ratio (Gregory et al., 1998); therefore, BCS is regarded as a valid 
measure/estimate of total energy reserves (Bewley and Schutz, 2008, Roche et al., 
2009). Although the subjective nature of BCS remains a challenge (Roche et al., 
2009), there is high repeatability and inter-observer agreement when assessors 
have been trained. However, accuracy of scoring is lower in cows with BCS 
below 3.0 or above 7.0, or when assessors have limited experience (Ferguson et 
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al., 1994, Roche et al., 2009). Body condition score is widely accepted as the 
primary measure of energy reserves in the dairy industry, upon which 
recommendations and management decisions are based (Alawneh et al., 2012, 
Buckley et al., 2003, Oltenacu and Broom, 2010, Roche et al., 2009). 
4.2 Inter-lactation profile of Body Condition 
changes  
All mammals are able to lose condition to support milk production in early 
lactation (Dall and Boyd, 2004). Elasticity of body energy reserves is an important 
feature of the mammalian reproductive strategy, because it buffers the offspring 
against unreliable food supplies (Dall and Boyd, 2004, Friggens et al., 2013, 
Roche et al., 2009). However, the dairy cow is extreme in this regard, losing large 
amounts of BCS for 50-100 days post-calving and only re-gaining BCS slowly, if 
at all, in mid-late lactation (Figure 13; Roche et al., 2007a). Genetically driven 
changes increase lipolysis and partitioning of nutrients to the mammary gland, at 
the onset of lactation (Chilliard et al., 2000, Friggens et al., 2013, Lucy, 2003). As 
lactation progresses, the partitioning of nutrients eventually swings back towards 
increasing body reserves and pregnancy, rather than millk production (Friggens et 
al., 2013, Yan et al., 2006). The inter-lactation profile of BCS change is affected 
by three things primarily: genetics, nutrition, and BCS at calving. 
 
Figure 13. The inter-calving BCS profile of grazed dairy cows (source: Roche et al., 
2007a). 
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 Genetic effects on the inter-calving BCS profile 4.2.1
Intense selection for increased milk production has exaggerated the homeorhetic 
response to lactation, increasing the partitioning of nutrients from body reserves 
toward milk (Friggens et al., 2013) and increasing the degree and duration of 
negative energy balance post-partum (Oltenacu and Broom, 2010). Breeding has 
increased early lactation milk production but this has not been accompanied by a 
comparable increase in dry matter intake (Goff, 2006, Roche et al., 2009, Van 
Arendonk et al., 1991) with peak dry matter intake lagging behind peak milk yield 
by several weeks (Berry et al., 2006, Oltenacu and Broom, 2010, Roche et al., 
2009). Dairy strains within breed differ in their propensity to lose BCS, depending 
on the intensity of selection for high milk production (Friggens et al., 2013, Lucy 
et al., 2009, Macdonald et al., 2008, McCarthy et al., 2007, Piccand et al., 2013, 
Pyman and Macmillan, 2010, Roche et al., 2006, Yan et al., 2006). For example, 
North American Holstein-Friesian cows partition more energy to lactation and 
lose more BCS in early lactation, and additional energy intake does little to 
ameliorate BCS loss, compared with New Zealand Holstein-Friesian cows in the 
same herd (Lucy et al., 2009, Macdonald et al., 2008). Genetic drive for 
production is such that offering a more energy dense diet in early lactation often 
results in higher milk production without improvement in post-partum energy 
balance (Roche et al., 2006, Roche et al., 2009). 
 Nutrition and system effects on inter-calving BCS profile 4.2.2
In all systems, cows lose BCS in early lactation, before ideally returning to the 
desired BCS before the next calving (Berry et al., 2006, Roche et al., 2007a, 
Roche et al., 2009). In systems where cows are fed large amounts of energy dense 
supplements, cows lose less BCS postpartum and the rate of BCS gain post-nadir 
is greater than in grazing cows receiving little supplementation (Figure 14; Roche 
et al., 2007a, Roche et al., 2009). In fact, cows in such systems may require feed 
restriction to ensure they are not over-conditioned at calving (Wildman et al., 
1982). In contrast, the BCS of cows in pasture-based systems in NZ tends to 
plateau and even decline for a period during summer, when pasture is of lower 
quality (Roche et al., 2007a). As a result, dairy cows end lactation thinner than 
they would in systems offering large amounts of concentrate feeds (Roche et al., 
2007a) and either calve at less than optimal BCS  or require extra feeding to 
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regain an ideal BCS prior to calving. Although the BCS toward the end of 
lactation and into the dry period differs depending on the feed system, the loss of 
BCS in early lactation is common to dairy cows in all systems. 
 
Figure 14. The inter-calving BCS profile of grazing cows (∆, heavy line) is different to 
the inter-calving BCS profile of TMR-fed cows (■, light line), although cows lose BCS 
for the first 50 days of lactation in both systems. Body condition score was assessed on 
the New Zealand 1 to 10 scale (source: Roche et al., 2007a). 
 
 Calving BCS and the inter-calving BCS profile. 4.2.3
There are moderate correlations between BCS at different stages of lactation 
(Berry et al., 2007a, Roche et al., 2007c). Cows that have low BCS at calving will 
usually have lowest BCS in the herd throughout lactation, and high BCS cows 
will usually be highest BCS throughout lactation (Berry et al., 2007a, Roche et al., 
2007c). As illustrated in Figure 15, there is a positive relationship between calving 
BCS and rate of BCS loss postpartum, such that cows that calve at high BCS lose 
more condition and experience a more severe negative energy balance (NEB) than 
cows that are low BCS at calving (Roche et al., 2007a, Ruegg and Milton, 1995). 
Together these results suggest that body condition score at nadir and mid-
lactation, and BCS loss postpartum are largely determined by BCS at calving, 
because feeding and management have little influence over BCS change (Roche et 
al., 2009). 
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Figure 15. Inter-calving BCS profiles for cows calving at a BCS of ≤3.5 (■), 4.0 (▲), 4.5 
(X), 5.0 (♦), 5.5 (●), or ≥6.0 (+). Body condition score was assessed on the New Zealand 1 
to 10 scale (source: Roche et al., 2007a). 
4.3 Associations between BCS and milk 
production and reproductive performance  
There is general agreement in the literature that BCS at calving and loss of BCS, 
or NEB, during early lactation have a significant effect on milk production and 
reproduction (Bewley and Schutz, 2008, Roche et al., 2009). However, because 
BCS at calving has a strong influence on the energy balance of a cow in early 
lactation and because early lactation NEB is not substantially affected by feed or 
management in an otherwise healthy cow during very early lactation, BCS at 
calving is the most important BCS target on the lactation calendar (Roche et al., 
2009).  
 Milk production 4.3.1
Higher BCS at calving and greater BCS loss postpartum are associated with 
higher lactation milk yield (Bewley and Schutz, 2008, Roche et al., 2009). The 
relationship between calving BCS and milk yield is curvilinear; milk yield 
increases with BCS but the increase in milk relative to BCS diminishes up to BCS 
6.5, beyond which, milk yield declines (Berry et al., 2007a, Roche et al., 2007b). 
There is a similar non-linear relationship between BCS lost postpartum and milk 
yield in the subsequent lactation, with increasing milk yield up to 1.5 BCS units 
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loss and decreased yield when BCS loss exceeds this value (Berry et al., 2007a, 
Roche et al., 2007b).  
 Reproduction 4.3.2
Reproductive performance generally improves with increasing calving BCS 
(Bewley and Schutz, 2008, López-Gatius et al., 2003, Roche et al., 2009). Higher 
BCS at nadir and smaller BCS loss between calving and nadir are associated with 
shorter postpartum anoestrus intervals and increased pregnancy rates (Beam and 
Butler, 1999, Markusfeld et al., 1997, Roche et al., 2009, Roche et al., 2007c). 
Greater BCS at calving contributes to better reproductive performance by 
association with nadir BCS; however, as with milk production, excessive 
postpartum BCS loss in cows with very high calving BCS may diminish the 
positive effect of high BCS (Roche et al., 2009) . 
4.4 Calving BCS and health 
Associations between BCS and various measures of health have been studied 
extensively and are less clear than relationships between BCS and milk 
production or reproduction (Roche et al., 2009). Low BCS is associated with 
greater morbidity (Gearhart et al., 1990, Hoedemaker et al., 2009); however, this 
relationship may reflect the effect of disease on BCS rather than the effect of BCS 
on disease incidence. A positive relationship between calving BCS and metabolic 
health is regularly observed but the relationship between calving BCS and 
resistance to infectious disease is ambiguous. Some studies have reported 
relationships between BCS or energy balance and immune function. Leptin, 
oxidative stress, and NEB are reported to modify the type-1/type-2 bias of 
immune function; however, these factors have primarily been studied in vitro, and 
independently of each other, and therefore it is unclear how such factors translate 
to disease resistance in the cow during the transition period. 
 Metabolic disease 4.4.1
Excessive loss of BCS combined with very high milk production, often occurring 
in cows with higher calving BCS, contributes to the development of several 
metabolic disorders, including ketosis, fatty liver, milk fever and displaced 
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abomasum (Bewley and Schutz, 2008, Goff and Horst, 1997, Roche et al., 2009, 
Rukkwamsuk et al., 1999). 
Ketosis and fatty liver:  Most studies report increased risk of ketosis and fatty 
liver in cows with high BCS at calving (Bewley and Schutz, 2008, Roche et al., 
2009). High rates of gluconeogenesis, such as occurs in early lactation, deplete 
hepatic oxaloacetate; consequently, oxaloacetate is limiting for oxidisation of 
NEFA and a greater proportion of NEFA are used for ketogenesis or accumulated 
as triglycerides in hepatocytes  (Goff and Horst, 1997, Roche et al., 2009, 
Rukkwamsuk et al., 1999). Excessive accumulation of triglycerides (fatty liver) 
decreases gluconeogenic capacity, which exacerbates the NEB and induces further 
lipid mobilisation (Rukkwamsuk et al., 1999, Wathes et al., 2009). Depressed 
gluconeogenesis causes ketosis, which is characterised by lethargy, reduced dry 
matter intake (DMI) and decreased milk production. Ketosis is diagnosed by 
elevated ketone levels in blood and urine (Goff and Horst, 1997). Cows that are 
greater than BCS 6.0 at calving are twice as likely to develop ketosis when 
compared to cows with a BCS of 5.5 at calving (Gillund et al., 2001). 
Milk fever:  Risk of hypocalcaemia, or milk fever, is increased in cows with high 
BCS at calving due to their high milk production and greater NEB (Roche and 
Berry, 2006). Milk fever occurs when secretion of milk calcium far exceeds 
dietary intake of calcium and plasma calcium concentrations are inadequate for 
muscle and nerve function (Goff and Horst, 1997, Roche et al., 2009). Cows that 
calve below BCS 3.5 also have a higher risk of developing milk fever than 
moderately conditioned cows, although the reason for this in unclear (Roche and 
Berry, 2006, Roche et al., 2009).  
Generally, the risk of metabolic disorders is higher in cows that calve at higher 
BCS because they produce more milk from nutrients released from body stores 
rather than from DMI. 
 Incidence of infectious disease. 4.4.2
The relationship between BCS and the incidence of infectious disease is 
inconsistent. Generally disease incidence is too low to accurately identify 
differences in susceptibility between different BCS groups, with the exception of 
intramammary and uterine infections. Most studies have reported no relationship 
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between calving BCS and incidence of clinical mastitis (Breen et al., 2009, 
Gearhart et al., 1990, Heuer et al., 1999), whereas, Berry et al. (2007b) reported a 
weak positive relationship between calving BCS and incidence of intramammary 
infection in mature cows, and a negative relationship in young cows. Similarly, 
the relationship between BCS and uterine infection is unclear. High rates of fat 
mobilisation before or after calving are reported to increase the incidence of 
metritis (Bewley and Schutz, 2008, Kaneene et al., 1997, Moyes et al., 2009a, 
Ospina et al., 2010, Roche et al., 2009). However, low BCS at calving is usually 
associated with greater incidence of uterine infection or inflammation, especially 
in young cows (Bewley and Schutz, 2008, Hoedemaker et al., 2009, Markusfeld et 
al., 1997, Roche et al., 2009), although Huzzey et al. (2009) reported no 
association between pre-partum BCS and metritis. The tendency for low BCS to 
be associated with a greater risk of mammary and uterine infections in young 
cows, but not in older cows, indicates that NEB, which is more severe in older 
cows, may influence the relationship between BCS and immune function. 
Much of the research examining these relationships is drawn from 
epidemiological studies, and as such it is difficult to determine whether the 
relationship is causative or associative. For example, the low BCS of a cow that 
presents with a uterine infection post-calving may be a consequence of the 
infection, rather than the cause of increased risk of infection (Roche et al., 2009). 
Some associations between BCS and incidence of infectious disease may be 
mediated by the effects of metabolic disease rather than by altered immune 
function. For example, cows with high calving BCS are at greater risk of milk 
fever and the consequent reduction in muscle function may reduce effectiveness 
of the teat sphincter and impair the expulsion of placenta, increasing the risk of 
mastitis and metritis, respectively (Goff and Horst, 1997).  
Another challenge to determining the nature of relationships as identified from 
epidemiological studies is that many studies do not record BCS at calving, or 
before calving, so the „calving‟ BCS may in fact refer to BCS measured several 
days to several weeks after calving (e.g. Heuer et al., 1999, Ruegg and Milton, 
1995). Approximately 1/3 of the total BCS that a cow loses during early lactation 
is lost in the first 10 days post-partum (Roche et al., 2007a), and this BCS loss is 
exacerbated by infection (Ruegg and Milton, 1995). Therefore, any BCS recorded 
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more than 1-2 days post calving cannot be accurately used to determine the 
relationship between calving BCS and incidence of disease.  
Equally, many reports are focussed on the relationship between over-conditioning 
at calving and subsequent health, rather than on under-conditioning. In the New 
Zealand dairy industry and in grazed dairy systems generally, low BCS at calving 
is more common than high BCS at calving, and average BCS tends to be lower 
throughout lactation, than in total mixed ration (TMR) systems (Roche et al., 
2007a, Washburn et al., 2002). 
 Recommended body condition scores are based on 4.4.3
relationships between BCS, milk production, fertility and 
metabolic disease. 
The relationships between BCS and milk production, reproductive performance 
and risk of metabolic disease, have led to the development of BCS targets that aim 
to optimise milk yield, fertility and health. For the New Zealand dairy industry, 
the recommendation is for mature cows to calve at 5.0, and young cows to calve 
at 5.5 BCS. Although calving BCS is positively associated with increased milk 
yield, the association between higher calving BCS and greater risk of metabolic 
disease means that there is little benefit in moving calving BCS of mature cows 
from 5.5 to 6.5.  
Young cows have lower milk yield and don‟t experience such severe NEB 
postpartum; therefore they are less susceptible to metabolic disease. Furthermore, 
young cows tend to be less dominant in the herd and so are less likely to regain 
adequate BCS before mating and before subsequent calving (Bewley and Schutz, 
2008, Ruegg and Milton, 1995). In addition, the interaction between calving BCS, 
parity and animal health measures suggest additional BCS at calving in younger 
cows is beneficial. Additional recommendations are to avoid cows losing more 
than 1.0 BCS after calving and for cows to be BCS 4.0 or greater by the start of 
mating. However, as described, famers have little influence over postpartum BCS 
loss; therefore, the most important target is calving BCS. 
It is apparent from the relationship between reproduction and BCS that when BCS 
or energy status is low, non-essential functions are compromised in favour of milk 
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production in early lactation. Yet there is limited research examining the 
relationship between low BCS at calving and immune function, and the 
recommendations for farmers do not incorporate immune competence, apart from 
considering the effects of BCS on the incidence of mammary and uterine 
infections. The incidence of other diseases may be relatively low but collectively 
their impact on productivity and welfare is substantial and warrants direct 
investigation of the relationship between BCS at various stages of the lactation 
cycle and immune function.  
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Chapter 5. Interface between BCS and 
immune function 
5.1 Functional trade-offs 
An animal that has large energy reserves can normally afford a more competent 
immune system (Houston et al., 2007, Lochmiller and Deerenberg, 2000). 
However, when energy intake is insufficient, an animal must divert nutrients from 
non-essential functions, such as growth or immunity, to those functions essential 
to survival, such as brain function (Demas, 2004, Houston et al., 2007, Lochmiller 
and Deerenberg, 2000). Once significant investment has been made in 
reproduction, the survival of offspring generally takes priority over immune 
function (French et al., 2007). This is reflected in the capacity for mammals to 
mobilise adipose and muscle tissue to support pregnancy and lactation (Dall and 
Boyd, 2004, Roche et al., 2009). During lactation, the ability of the mammary 
gland to take up glucose independent of insulin means that milk production is 
afforded higher priority for nutrient resources than reproductive tissues.  
Low body fat reserves are associated with altered immunity in many species 
(Demas, 2004, French et al., 2011). When energy reserves/supply are limited, 
type-1 responses are inhibited and type-2 responses are favoured, most likely 
because a type-1 cellular response consumes more energy and protein than a type-
2 antibody response, although both may be impaired by nutritional deficiency 
(Demas, 2004, Fekete and Kellems, 2007, Gilot-Fromont et al., 2012, Lochmiller 
and Deerenberg, 2000). For example, wild deer living in a low resource 
environment and, therefore were in poor body condition, had less circulating 
neutrophils and lower serum APP, higher circulating antibodies, higher circulating 
lymphocytes and monocytes, and lower CD4+/CD8+ and IFN-γ:IL-4 ratios, than 
deer living in a high resource environment (Gilot-Fromont et al., 2012). Similarly, 
low BCS cows (BCS < 3.75) in mid-lactation have reduced numbers of T cells 
and reduced cytokine expression, particularly IFN-γ, resulting in a lower IFN-
γ:IL-4 ratio when compared to higher BCS cows (Ohtsuka et al., 2009). Cows of 
moderate body condition (BCS 4.0-5.0) in mid-lactation have lower circulating 
TNF-α and lower TNF-α production in response to lipopolysaccharide than cows 
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with BCS greater than 6.5 (O'Boyle et al., 2006). These results support the 
concept of a type-2 biased immune system in cows with lower BCS.  
5.2 Leptin 
The bias toward type-1 or type-2 immune responses, in relation to degree of 
adiposity, is possibly mediated by leptin, a hormone secreted primarily by 
adipocytes and which increases in direct proportion to adiposity (Borghetti et al., 
2009, French et al., 2011, Lago et al., 2008, Meyers et al., 2005). The 
concentration of leptin signals energy status, facilitating functional trade-offs 
during periods of limited resource, for example, suppressing immune 
responsiveness to conserve energy for vital organs (Abrams and Miller, 2011, 
Block et al., 2001, French et al., 2007, French et al., 2011, Ingvartsen and 
Boisclair, 2001, Matarese and La Cava, 2004). Most immune cells possess leptin 
receptors, including macrophages and T- and B-lymphocytes (Fenandez-
Riejos10). Administration of leptin to rodents with limited energy availability 
restores adaptive immune responses (Demas, 2004, Lord et al., 1998), indicating 
that suppression of immune function is facultative rather than obligatory (French 
et al., 2007). Leptin suppresses expression of type-2 cytokines and, therefore, 
decreases antibody responsiveness (Lago et al., 2008, Meyers et al., 2005). Leptin 
also induces ROS secretion from neutrophils and expression of inflammatory 
cytokines by macrophages and dendritic cells (Borghetti et al., 2009, Lago et al., 
2008, Meyers et al., 2005). Naïve T-lymphocytes that are activated in the resulting 
inflammatory cytokine milieu are polarised toward a type-1 cytokine expression 
pattern (Lago et al., 2008, Meyers et al., 2005). The sum effect of high leptin 
levels is to support a type-1 immune response bias in animals with ample energy 
reserves and to inhibit type-1 in favour of type-2 responses in animals of limited 
energy reserves (Borghetti et al., 2009, Lago et al., 2008, Meyers et al., 2005). 
5.3 Oxidative stress 
Oxidative stress and the consequent inflammatory state generated may contribute 
to greater immune dysfunction in high BCS cows. Immune cells are sensitive to 
oxidative stress because the lipids in their cell membranes are vulnerable to 
peroxidation and because immune cells produce high quantities of ROS (Esposito 
et al., 2014, Spears and Weiss, 2008). Elevated leptin levels increase neutrophil 
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production of ROS (Lago et al., 2008), and postpartum, the metabolic demand of 
high milk production and rapid lipolysis accelerate ROS production in all tissues 
(Esposito et al., 2014, Morris et al., 2009)  Additionally, elevated NEFA 
concentrations change the activity of serum albumin from antioxidant to pro-
inflammatory (Contreras and Sordillo, 2011). Consequently, oxidative stress 
occurs because antioxidant pools are depleted by excessive ROS production. 
Cows with higher BCS pre-calving and greater BCS loss post-partum have lower 
antioxidant potential and higher levels of reactive oxygen metabolites and markers 
of peroxidative damage to cell membranes, indicative of oxidative stress 
(Bernabucci et al., 2005). Oxidative stress and, consequently, systemic 
inflammation increase with adiposity (O'Boyle et al., 2006), and would possibly 
exacerbate the type-1 bias observed in high BCS cows. 
5.4 Negative energy balance 
High BCS promotes type-1 immune bias through the effects of leptin and 
oxidative stress; however, the relationship between BCS and immune function is 
complicated by NEB during the post-partum period. The onset of lactation and 
NEB causes a rapid decrease in serum leptin, with the decline greatest in cows 
with higher calving BCS (Block et al., 2001, Kokkonen et al., 2005, Meikle et al., 
2004). During the postpartum period, serum leptin levels in high BCS cows are 
almost as low as those observed in low BCS cows (Kokkonen et al., 2005). Since 
leptin levels are similar between high and low BCS cows during the post-partum 
period, both high and low BCS cows might have inhibited type-1 responses in 
favour of type-2 responses. 
Additionally, as a consequence of NEB, postpartum serum NEFA and ketone 
body concentrations are usually higher in cows with high BCS. Higher 
concentrations of serum NEFA and ketone bodies are associated with a higher 
incidence of retained placenta, metritis, and mastitis (Holtenius et al., 2004, 
Kaneene et al., 1997, Moyes et al., 2009a, Ospina et al., 2010). Neutrophils 
incubated with NEFA and/or ketones, or isolated from ketotic cows, have reduced 
ROS production and NET formation, impaired phagocytosis and chemotaxis, and 
reduced viability (Grinberg et al., 2008, Scalia et al., 2006), although intracellular 
killing is not consistently affected (Grinberg et al., 2008, Suriyasathaporn et al., 
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2000). Higher concentration of serum NEFA, but not ketones, has been associated 
with decreased levels of circulating natural antibodies (van Knegsel et al., 2012). 
Incubation or exposure to elevated NEFA concentrations is reported to impair 
several lymphocyte functions in vitro, including proliferation (Lacetera et al., 
2004, Ster et al., 2012), antibody production (Lacetera et al., 2004), and 
production of pro-inflammatory cytokines (Lacetera et al., 2004, Ster et al., 2012). 
Franklin et al. (1991) and Sato et al. (1995) reported impaired lymphocyte 
proliferation in the presence of elevated ketone concentrations; whereas, Ster et al. 
(2012) found no effect of ketone concentration on in vitro lymphocyte 
proliferation, and Ster et al. (2012) and Nonnecke et al. (1992) reported no effect 
on in vitro production of inflammatory cytokines. In any case, both NEFA and 
ketone body concentrations are more elevated postpartum in cows that calve with 
higher BCS; therefore, cows that calve in high BCS probably have more severe 
impairment of lymphocyte function postpartum than cows with lower calving 
BCS. 
5.5 In vivo evidence for the relationship between 
BCS and immune function at calving 
It is well documented that greater NEB contributes to immune dysfunction in 
dairy cows during the transition period. However, it is not entirely clear how the 
interplay between calving BCS and NEB affects immune response bias, 
particularly in low BCS cows. Most research has been directed at high BCS cows, 
rather than low BCS, because excessive BCS at calving is more prevalent in many 
dairy systems. However, in systems that rely heavily on seasonal grass growth, 
such as in NZ, low to moderate BCS at calving is typical (Roche et al., 2007a). 
Additionally, the energy allowance offered to dairy cows before calving is lower 
in NZ, than other countries; limited pasture availability means that cows in 
systems reliant on seasonal grass growth are usually partially underfed in the last 
few weeks pre-calving (Holmes et al., 2002, Stafford and Gregory, 2008). The 
level of energy intake pre-calving is reported to affect adaptation to lactation, with 
reduced postpartum NEB, fewer metabolic diseases, reduced systemic 
inflammation, lower oxidative stress, and better neutrophil function in cows that 
were fed a lower energy diet pre-partum (Graugnard et al., 2012). Consequently, 
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the relationships between calving BCS and immune function reported previously 
may not translate to the NZ system. 
There has been limited in vivo research investigating the relationship between 
BCS and immune function; however, what research has been done indicates that 
cows that calve in high BCS exhibit greater impairment of immune function post-
partum, than in lower BCS cows. Lacetera et al (2005) reported that the degree of 
impairment of both type-1 and type-2 lymphocyte functions was proportional to 
BCS loss, being greatest in cows with higher BCS at calving. Lymphocytes 
isolated from cows with BCS below 4.0 pre-calving had higher IFN-γ responses, 
before and after calving, and higher IgM responses after calving, than 
lymphocytes collected from cows of BCS > 6.5 and BCS 4.5-6.0. Ohtsuka et al. 
(2008) reported that cows which lost the most body weight postpartum, and 
presumably had higher calving BCS, had a type-2 biased immune cell population, 
with lower CD4:CD8 and IFN- γ:IL-4 ratios. These results contradict what is 
observed outside the periparturient period and indicate that the NEB may 
counteract the type-1 immune response bias associated with high BCS cows 
during other stages of the inter-calving profile. Cows with the lowest energy 
balance postpartum likely have the lowest leptin levels, because leptin indicates 
energy status in terms of both reserves and demand on reserves, and this may 
contribute to greater type-2 bias in cows experiencing greater NEB postpartum. 
5.6 Summary and hypotheses 
Management of cows during the transition between pregnant and lactating states 
is one of the key determinants of cow welfare and the profitability of a dairy 
enterprise (Drackley, 1999, Mulligan and Doherty, 2008). Despite this, there is 
still much that isn‟t understood about the transition period. In particular, the role 
of calving BCS on the post-partum health of dairy cows is poorly understood. The 
New Zealand dairy industry has established a target calving BCS of 5.0 for mature 
cows and 5.5 for first and second calvers (DairyNZ body condition scoring: The 
reference guide for New Zealand dairy farmers, 2012). This target is optimal for 
production, fertility and metabolic health (Roche et al., 2009, Roche et al., 
2013b); however, the relationship between calving BCS and infectious disease is 
not well understood. There is evidence from epidemiological and in vitro studies 
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that the degree of periparturient immune dysfunction is influenced by the extent of 
the NEB in early lactation (Lacetera et al., 2005, Lacetera et al., 2004, Ohtsuka et 
al., 2008). Since farmers have limited ability to manipulate energy balance in 
early lactation (Roche et al., 2006, Roche et al., 2009), management of BCS at 
calving would be the most accessible way to manage periparturient immune 
dysfunction, if that link exists. 
This study will investigate the effect of BCS at calving on AMIR and CMIR of 
dairy cows in early lactation. Antigen-specific antibody produced in response to 
immunisation with type-2 antigens will be used as the measure of AMIR and 
delayed-type hypersensitivity (DTH) against Candida albicans will be used as the 
measure of CMIR. These in vivo measures have been used extensively in Canada 
and Ireland; however, the CMIR measure relies on low background exposure to C. 
albicans. Therefore, the first objective is to investigate the level of background 
exposure to C. albicans, indicated by magnitude of DTH responses, in a pasture-
based herd. 
To address the main objective, the energy levels of healthy cows will be 
manipulated to achieve specific BCS at calving. Post-partum AMIR and CMIR 
will be compared with responses measured during the previous lactation, when all 
cows had similar BCS. In addition to measuring DTH and antigen-specific IgG, 
the ratio of antigen-specific IgG1:IgG2 in response to immunisation with type-2 
antigen will be measured as an indicator of type-1/type-2 bias. The hypotheses for 
this study are: 
1. Cows in a New Zealand pasture-based herd have small DTH responses 
relative to cows immunised with C. albicans. 
2. The degree of immune suppression is positively correlated with BCS at 
calving. 
3. Degree of type-2 bias is positively correlated with BCS at calving.  
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Chapter 6. Experiment One: Induction of 
delayed-type hypersensitivity reactions to 
Candida albicans in pasture-based dairy cows 
 
6.1 Introduction 
Selection for production traits with little or no emphasis on health traits has led to 
an increase in the incidence of disease in dairy herds (Oltenacu and Broom, 2010). 
Development of methods to assess immune response phenotypes in pasture-based 
NZ dairy cattle will allow selection pressure to be placed on health traits, and 
when used in combination with selection for important production traits, improve 
productivity, health & welfare in dairy herds. Cell-mediated immunity is crucial 
to protection against viruses and other intracellular parasites (Baldridge and Ward, 
1997). Delayed-type hypersensitivity (DTH) reactions are localised cell-mediated 
immune responses (CMIR), mediated primarily by antigen-specific CD4+ T-
lymphocytes which act to recruit macrophages to the reaction site. DTH reactions 
generally occur in response to intracellular pathogens (Baldridge and Ward, 1997, 
Kobayashi et al., 2001) and are marked by a hard swelling at the site 24-72 hours 
later post antigen exposure (Rosenstreich, 1993). A DTH response only occurs if 
the animal has been exposed to the antigen previously and has memory T-
lymphocytes specific for the antigen (Rosenstreich, 1993). 
Delayed-type hypersensitivity is an accepted in vivo measure of CMIR in many 
species, including humans, rodents and pigs (Hessing et al., 1995, Martin et al., 
2008, Neuvonen and Salo, 1984). To assess CMIR in cattle, DTH responses to the 
intracellular yeast Candida albicans have been used (Heriazon et al., 2011). 
Importantly, the use of C. albicans does not interfere with the diagnosis of bovine 
infectious diseases, such as Tuberculosis (Heriazon et al., 2009a). C. albicans is a 
common commensal of many mammals and it has been reported that dairy cows 
produce a mild DTH response to C. albicans without priming suggesting previous 
natural exposure (Heriazon et al., 2009a). To minimise the effects of individual 
variability in background exposure most DTH testing protocols involve priming 
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the test animals by immunising with C. albicans prior to DTH testing to generate 
an expanded pool of antigen-specific T-lymphocytes. Immunised animals respond 
more consistently and display larger responses than cows that have not been 
immunised (Heriazon et al., 2009a). 
Measurement of DTH responses to C. albicans has been used successfully in 
Canadian and Irish dairy herds to assess CMIR (Begley et al., 2009b, Heriazon et 
al., 2009a, Mallard, 2007) but has not been investigated in NZ dairy herds. Cows 
assessed in both the Canadian and Irish dairy herds spend a large proportion of 
their time in housed environments. This is in contrast to NZ dairy herds which are 
predominantly pasture-based and not housed for extended periods of time. There 
has been limited research about the prevalence of C. albicans in dairy-farm 
environments because it is not an important cause of disease (Heriazon et al., 
2009a, Richard et al., 1980); however, it is plausible that housed cows are 
exposed to different pathogens and have different commensal micro-flora to their 
pasture-based counterparts. For example, cows that are permanently housed have 
a higher prevalence of digital dermatitis than cows with access to pasture 
(Holzhauer et al., 2012, Laven and Holmes, 2008), and the prevalence of mastitis-
causing pathogens is different in pasture-based versus housed cows (Laven and 
Holmes, 2008). 
Differences in pathogen and commensal micro-flora exposure between farming 
systems may also extend to exposure to C. albicans. Yeast are isolated from a 
lower proportion of milk samples submitted for bacteriological culture in New 
Zealand (0.3%; Petrovski et al., 2011), than in other countries (1.3% to 25%; 
Casia dos Santos and Marin, 2005, Hayashi et al., 2013, Moretti et al., 1998), 
indicating that exposure to C.albicans might be lower in New Zealand herds. If 
natural exposure to C. albicans is not consistently low in pasture-based cows then 
background exposure would need to be determined prior to priming with antigen 
and subsequent DTH testing, or an alternative antigen used to elicit the DTH 
response. The primary objective of this experiment was to determine the 
magnitude of background DTH responses to C. albicans in New Zealand pasture-
based dairy cows and ascertain whether C. albicans is a suitable antigen to elicit 
measurable DTH responses for assessment of immune responsiveness on farm. 
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6.2 Methods 
The experiment was conducted at the DairyNZ Lye Farm, Hamilton (37°76‟S 
175°37‟E, 45 m above sea level), during November and December 2010. All 
procedures were approved by the Ruakura Animal Ethics Committee, Hamilton, 
New Zealand, in accordance with the New Zealand Animal Welfare Act 1999. 
 Animals and Immunisation. 6.2.1
Twenty healthy, mid-lactation dairy cows of mixed age and breed were selected 
from the Lye Farm research herd (DairyNZ Ltd, Hamilton, New Zealand). The 
Lye Farm herd is milked twice per day and grazes a ryegrass and white clover 
pasture, with pasture silage and maize silage offered when pasture is limited. The 
cows were run together in their normal herd, and no supplementary feed was 
offered, for the duration of this experiment. Average milk production at the time 
of experiment was 22.3kg per cow per day. The cows were run together in their 
normal herd for the duration of the experiment. Cows were grouped on body 
condition score (BCS) and then cows within each BCS group were randomly 
assigned to one of two experimental groups; immunised (n=10), control (n=10). 
For the immunised group, the mean age was 4.1 ± 1.6 yr (mean ± SD) and mean 
BCS was 3.8 ± 0.4 (1-10 BCS scale, where 1 is emaciated and 10 obese; Roche et 
al., 2004). For the unimmunised group, the mean age was 4.6 ± 1.9 yr and the 
mean BCS was 3.8 ± 0.3.  
The immune testing protocol involved immunisation on d0 and d14, followed by 
DTH testing on d21, as described by Heriazon et al. (2009b). Cows in the 
immunised group received an intramuscular (IM) injection of 0.5 mL of 
phosphate-buffered saline (PBS, pH7.4) containing 0.5 mg of type-1 antigen C. 
albicans (CaWC, My15 crude whole cell; Greer Laboratories Inc, Lenoir, NC, 
USA) and 0.5 mg of adjuvant (QuilA, 848051, Brenntag Biosector A/S, 
Frederikssund, Denmark) on D0 and D14. The injection also contained 0.5 mg of 
type-2 antigen; either hen egg-white lysozyme (HEWL) or human serum albumin 
(HSA). Immunisation with HEWL (n=5) or HSA (n=5) did not significantly 
influence DTH responses (P>0.05), therefore DTH responses from these cows 
were combined (immunised group, n=10) for analysis. Cows in the control group 
received an IM injection of 0.5mL PBS on day 0 (d0) and d14 (n=5), or received 
 56 
 
no injection (n=5). Immunisation with saline or receiving no immunisation did not 
significantly influence DTH responses (P>0.05), therefore DTH responses from 
these cows were combined (unimmunised group, n=10) for analysis. 
 Delayed-type Hypersensitivity. 6.2.2
The DTH skin test was performed on all cows on d 21, in the caudal skin folds on 
either side of the tail, as described previously (Heriazon et al., 2009a, Hine et al., 
2011). Briefly, 0.1 ml PBS alone (control) or containing either 0.1mg of CaWC 
(test) were injected intradermally into the skin fold on opposite sides of the tail. 
The site of each injection was marked with correction fluid (twink) to allow 
subsequent measurements in the same site. Double skin fold thickness (DSFT) 
measures (3 repetitions), were taken at both test and control sites, prior to 
injection (0 h) and 7, 24 and 47 h post injection, using a spring loaded calliper 
(Harpenden, Mentone Educational Centre, Victoria, Australia). Photos in Figure 
16 depict several stages of the DTH test. 
Hine et al (2011) defined a positive DTH response to CaWC as an increase in 
DSFT of >1mm at the test site relative to the control site. A similar criterion was 
used to define positive DTH responses in the current study. The number of cows 
that exhibited positive responses was calculated for each experimental group. The 
responses of all cows were included in statistical analyses, regardless of whether 
they met the threshold for a positive response. 
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Figure 16. Measurement of delayed-type hypersensitivity.  From top to bottom: 1) Twink 
lines are drawn on both caudal folds to facilitate consistent placement of spring loaded 
callipers.  2) An insulin needle was used to inject 0.1ml of test or control formula within 
the dermal layer of opposite caudal folds.  3) Spring loaded callipers were used to measure 
the thickness of the caudal fold immediately before the injection and at 7, 24 and 47 hours 
post-injection. 
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 Statistical Analyses. 6.2.3
For analysis, responses to DTH testing were expressed as the change in log of 
(DSFT at test site/DSFT at control site) from 0 h, as described by Hine et al. 
(2011): 
Response = log (Th/Ch) – log (T0/C0) 
Where Th = mean test DSFT at time h; T0 = mean test DSFT at 0 h; Ch = mean 
control DSFT at time h; C0 = mean control DSFT at 0 h; and time h was 7, 24 or 
48 h. This response variable was used for all statistical tests. Responses were 
analysed in SAS
®
 software (version 9.3, SAS Institute, Cary, NC, USA), using 
mixed models approach to repeated measures with time, treatment, and their 
interaction included as fixed effects. Tukey‟s test was used for pairwise 
comparisons. F-tests were used to determine whether the variability of DTH 
responses differed between immunised cows and unimmunised cows, and 
between 24 and 47 h for immunised cows. Pearson product-moment correlation 
coefficients were computed between 0 h DSFT of the test fold and maximum 
relative DSFT, and between 24 and 47 h for immunised cows. Significance is 
declared if P < 0.05. 
6.3 Results 
All cows had increased DSFT at the test site relative to the control site following 
the CaWC injection at 0 h. Seven of the ten unimmunised cows and nine of the 
ten immunised cows produced a positive DTH reaction. No positive reactions at 
control injection sites were observed. The responses observed at the test sites were 
limited to swelling of the caudal fold, with no apparent changes to the skin surface 
of any injection sites. 
Mean maximum relative DSFT increases were 4.3 mm (±1.4; SE) and 1.4 mm 
(±0.5) for immunised and unimmunised cows, respectively. Responses were 
larger in immunized cows at all time-points relative to unimmunised cows (Figure 
18). The increase in relative DSFT from 0 h to 7 h was 5-fold greater in 
immunised cows than in unimmunised cows. The maximum response was more 
variable in immunised relative to unimmunised cows (p<0.01). 
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The average DTH response for both groups peaked at 24 h but was not 
significantly greater than responses observed at 47 h (immunised: P = 0.649; 
unimmunised: P = 0.989). There was no difference in variability of 24 and 47 h 
responses in immunised cows (P = 0.788). Responses at 24 and 47 h were highly 
correlated in immunised cows (r
2 
= 0.79, P < 0.01). There was no correlation 
between maximum relative DSFT increase and 0 h test DSFT in the immunised 
group (r
2 
= 0.08, P > 0.05). 
The time-dependent DTH responses for individual animals in each group depicted 
in Figure 19 illustrate the increased variability of response magnitude in 
immunised cows. In the immunised group, the maximum relative DSFT increase 
was at 24 h for six cows, 47 h for three cows, and 7 h for one cow. In the 
unimmunised group, the maximum relative DSFT increase was at 24 h for four 
cows, 47 h for five cows, and 7 h for one cow (Figure 19). Examples of DTH 
responses in immunised cows are illustrated in Figure 17. 
 
Figure 17. Four examples of delayed-type hypersensitivity response, 24 hours after 
the injection.  In all photos, the test fold is on the left and the control fold is on the 
right.  The top right image shows an unusually strong DTH response with hard 
swelling spread up the caudal fold from the injection site. 
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Figure 18. Delayed-type hypersensitivity (DTH) response to Candida albicans whole-cell, in dairy 
cows previously sensitised via immunisation (n=10), and in unimmunised cows (n=10). Responses 
are expressed as change in the log of (double skin fold thickness at the test site/doubles skin fold 
thickness at the control site) from 0 h, measured at 7, 24 and 47 h post-injection. Error bars 
indicate 95% confidence intervals. Responses in immunised cows were significantly larger than 
responses in unimmunised cows at every time point (P < 0.05). 
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Figure 19. Delayed-type hypersensitivity responses to Candida albicans of individual dairy cows that were previously 
immunised with C. albicans (a) or unimmunised (b). Responses are expressed as relative increase in double skin fold 
thickness from 0 h relative to the control site, at 0, 7, 24 and 47 h post-injection. 
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6.4 Discussion 
Delayed-type hypersensitivity reactions to C. albicans have been used extensively 
in North American dairy cattle to assess cell mediated immune responsiveness 
(Heriazon et al., 2011, Heriazon et al., 2009a, Heriazon et al., 2009b, Hine et al., 
2011). Studies have shown that these largely housed dairy cows produce mild 
DTH responses to C. albicans as a consequence of natural exposure. Nevertheless, 
previous experiments have included priming the immune system by immunising 
with C. albicans prior to DTH testing to minimise the effects of individual 
variation in natural exposure and to stimulate greater DTH responses. Natural 
exposure levels of cows in New Zealand‟s pasture-based dairy herds may be 
different to their largely housed counterparts. Therefore, the objectives of this 
experiment were to investigate both background and pre-primed DTH responses 
of pasture-based dairy cows and to determine if DTH testing using C. albicans 
can be used successfully as an indicator of CMIR in pasture-based dairy cows. 
 Background DTH responses to C.albicans 6.4.1
Results of the current study demonstrate that the pasture-based NZ dairy cows in 
the herd tested had low level background DTH responses to C. albicans 
suggesting low level natural exposure to C. albicans. Although several 
unimmunised cows produced mild DTH responses, responses measured in 
immunised cows were much larger. Furthermore, responses were five-fold larger 
in immunised cows relative to unimmunised cows at 7 h post-injection. This 
contrasts with the results of Heriazon et al. (2009a), who reported that the 
magnitude of responses at 6 h were similar in immunised and unimmunized cows. 
Heriazon et al. (2009b) reported that cows immunised twice exhibited skin lesions 
such as pustules, crusting and dermatitis at the C. albicans injection site. In the 
current experiment, all DTH responses were limited to swelling of the caudal fold, 
with no apparent changes to the skin surface in immunised cows. These results 
indicate that the natural exposure to C. albicans was lower in the pasture-based 
cows tested here relative to housed cows and therefore, it is likely not necessary to 
determine background DTH prior to priming with C. albicans. The number of 
cows used to determine background DTH in this experiment was small (n=10), 
and the results pertain to a single farm. Testing of background DTH to C. albicans 
in other pasture-based herds, in varied geographical locations and operating under 
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various management systems will be required to confirm that natural exposure to 
C. albicans is typically low in pasture-based herds in New Zealand. 
 Pre-primed DTH responses in immunised cows 6.4.2
Results demonstrated that immunisation prior to conducting DTH testing 
successfully enhanced DTH responses. A greater proportion of positive DTH 
responses were observed in immunised cows and responses were three-fold larger 
at 24 and 47 h than in unimmunised cows. Testing of unimmunised cows showed 
that background sensitivity to C. albicans was consistently very low therefore the 
high variability observed in DTH responses from immunised cows is likely due to 
individual differences in immune responsiveness, rather than from differences in 
previous natural exposure to C. albicans. These results confirm that C. albicans 
can be successfully used to elicit measurable DTH responses in pasture-based 
cows to rank animals based on their cell-mediated immune responsiveness. 
 Kinetics of pre-primed DTH 6.4.3
In the current study, peak DTH response times varied between cows indicating 
that measurement at both 24 and 48 h may be better than either time-point alone. 
Delayed-type hypersensitivity reactions are characterised by a hard swelling at the 
site 24-72 hours post antigen exposure (Rosenstreich, 1993). While DTH 
responses at 7 h were significantly higher in immunised versus control cows, 
responses observed at 7 h are not expected to be indicative of true DTH responses 
but rather earlier phase immune reactions (Black, 1999, Hernández et al., 2005). 
Begley et al. (2009b) identified 48 h post dermal injection as the optimal time to 
assess DTH response. However, other researchers have measured DTH at both 24 
and 48 h and found no significant difference between the magnitude of DTH 
responses at each time-point (Heriazon et al., 2011, Heriazon et al., 2009a, 
Heriazon et al., 2009b, Hernandez et al., 2003). Heriazon et al. (2009b) reported 
that cell infiltration to the DTH site following injection with C. albicans was 
similar at 24 and 48 h and concluded that the response observed at both time 
points represented a classic DTH reaction. Hernandez et al. (2003) suggested that 
using the average of 24 and 48 h or selecting the time-point with greatest 
variability between cows is appropriate when using DTH responses to classify 
cows. In this experiment, 24 h responses were highly correlated with 47 h 
 64 
 
responses, however, for individual cows the time of peak response occurred 
equally at 24 and 47 h and ranking of cows based on the magnitude of the DTH 
response was variable between 24 and 47 h. Additionally, the variability was the 
same at 24 and 47 h. While measuring at 24 h would capture the peak response for 
most of the cows in the current experiment, our results suggest that DSFT should 
be measured at both time points when using DTH response to classify cows, as 
suggested by Hernandez et al. (2003).  
6.5 Conclusion 
Background exposure to C. albicans was minimal in the pasture-based New 
Zealand herd tested and DTH reactions to C. albicans can be successfully used as 
a measure of cell-mediated immune responsiveness. Cows produced only mild 
DTH responses to CaWC, when not pre-immunised with C. albicans. Furthermore 
immunised cows had a greater proportion of positive DTH responses, and 
produced significantly larger and more variable DTH responses than non-
immunised cows.  
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Chapter 7. Experiment Two - Adaptive 
immune responses in early lactation were not 
affected by body condition score at calving.  
7.1 Introduction 
Dairy cows exhibit transient immune dysfunction during the period of transition 
between pregnancy and lactation (Goff, 2006, Schwarm et al., 2013, Wagter et al., 
2000),  This is believed to contribute to a higher incidence and severity of 
infectious disease during the first few weeks of lactation (Drackley, 1999, Mallard 
et al., 1998, Vangroenweghe et al., 2005). In support of this hypothesis, 25 to 56% 
of clinical mastitis occurs in the three weeks after calving (Kehrli Jr, 2012, 
McDougall et al., 2007) and gastrointestinal worm burdens and egg counts are 
elevated in periparturient cows (Houdijk, 2008). These results indicate a reduced 
ability to resist new infection or contain latent subclinical infections during the 
transition period. 
Negative energy balance (NEB) may contribute to this impaired immune function. 
Homeorhetic adaptations support a rapid increase in milk production, but the 
increase in voluntary food intake is not sufficient to meet energy and protein 
requirements until several weeks after calving (Bauman and Currie, 1980, 
Oltenacu and Broom, 2010, Roche et al., 2009). Consequently, dairy cows are in 
negative energy and protein balance during early lactation (Drackley, 1999, 
Gearhart et al., 1990, Goff and Horst, 1997) and mobilize fat and protein from 
body tissues to support milk production (Morris et al., 2009, Roche et al., 2009). 
Fat mobilization elevates serum levels of NEFA and ketones, such as BHBA 
(Roche et al., 2009, Suriyasathaporn et al., 2000), and levels of these metabolites 
have been associated with increased incidence of retained placenta, metritis and 
mastitis (Kaneene et al., 1997, Moyes et al., 2009b, Ospina et al., 2010), and 
impaired lymphocyte and neutrophil function (Grinberg et al., 2008, Ster et al., 
2012, Suriyasathaporn et al., 2000). These results suggest that a greater level of 
immune dysfunction occurs in cows that experience a greater NEB postpartum, 
resulting in reduced ability to resist disease. The extent of postpartum NEB is 
 66 
 
positively correlated with BCS at calving (Broster and Broster, 1998, Roche et al., 
2007a, Roche et al., 2009); therefore, cows that calve at higher BCS might exhibit 
a greater degree of immune dysfunction than cows that calve at lower BCS. In 
support of this hypothesis, high BCS at calving has been associated with increased 
incidence of mastitis (Berry et al., 2007b, Morrow, 1976) and Lacetera et al. 
(2005) reported greater impairment of both IFN-γ and IgM secretion in cows that 
calved at higher BCS and lost more BCS post-calving. However, in contrast, low 
BCS has been associated with greater incidence of uterine infection (Hoedemaker 
et al., 2009, Markusfeld et al., 1997, Roche et al., 2009). Therefore, associations 
between calving BCS and cow health are not consistent (Breen et al., 2009, 
Gearhart et al., 1990, Heuer et al., 1999). Much of the research has been 
epidemiological, making it impossible to determine whether the relationship is 
causative or associative, and there has been limited in vivo research concerning 
the relationship between calving BCS and postpartum immune function. 
Additionally, limited research has been conducted in pasture-fed cows; this is 
important because, compared with cows in other systems, pasture-fed cows tend 
to calve at lower BCS (Roche et al., 2007a) and are exposed to different 
environmental pathogens (Laven & Holmes, 2008). 
The objectives of this study were to compare in vivo measures of adaptive 
immunity in pasture-fed cows postpartum, and to investigate the effect of 
differences in NEB associated with differing BCS at calving on adaptive immune 
function in early lactation. It was hypothesized that, as a result of more profound 
negative energy balance, cows that have higher BCS at calving would exhibit 
greater immune suppression during early lactation compared with cows calving at 
lower BCS. The immune system becomes type-2 biased during the periparturient 
period (Shafer-Weaver et al., 1999, Shafer-Weaver and Sordillo, 1997), and that 
type-2 shift is reported to be increased in cows with greater postpartum loss of 
BWT Ohtsuka et al. (2008). Since postpartum BWT loss is associated with BCS 
at calving, I hypothesised that cows with a higher calving BCS will exhibit a 
stronger type-2 bias than cows with lower calving BCS. To test these hypotheses, 
the energy balance of healthy cows at similar mid-lactation BCS was manipulated 
in late-lactation, to generate groups of cows with differing BCS at calving (Roche 
et al., 2013c). Antibody-mediated immune responses (AMIR) and cell-mediated 
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immune responses (CMIR) in early lactation were compared with responses 
measured in mid-lactation before BCS manipulation began. Previous studies have 
reported that cows with enhanced immune responsiveness as assessed with these 
immune testing protocols have decreased incidence of infectious disease, 
including mastitis, increased levels of antibody in colostrum, and respond more 
strongly to commercial vaccines (De La Paz, 2008, Mallard et al., 1997, Wagter et 
al., 2000). 
7.2 Method 
The experiment was conducted at the DairyNZ Lye Farm, Hamilton, New 
Zealand (37°76‟S 175°37‟E, 45 m above sea level) from January until September 
2011. All procedures had prior approval of the Ruakura Animal Ethics 
Committee, Hamilton, New Zealand, and are in accordance with the New Zealand 
Animal Welfare Act 1999. 
 Animals and BCS treatment 7.2.1
Sixty mid-lactation dairy cows of mixed age and breed between body condition 
score 3.75 and 4.25 (1-10 BCS scale, where 1 is emaciated and 10 obese; Roche et 
al., 2004) were enrolled in the study. All cows had no previous history of disease, 
including mastitis, were confirmed pregnant, and passed a veterinary clinical 
examination when enrolled in the experiment on 5
th
 January 2011 Cows were 
allocated randomly to treatment groups (High, Medium and Low, 20 cows per 
group) on 1
st
 February 2011, ensuring treatments were balanced for BCS at the 
time of enrolment, expected calving date, production, age, breed, somatic cell 
count and live weight. Age at enrolment was 4.0 ± 1.4 yr (mean ± SD). Mean 
expected calving date was 9 July ± 9 d. Fourteen cows in each group were 
Holstein-Friesian, with the balance being 75% Holstein-Friesian/25% Jersey 
cross. 
Between mid-lactation and calving, feeding levels were manipulated with the 
intention of generating three homogenous BCS groups before the end of lactation: 
3.0, 4.0 and 5.0, for the Low, Medium and High groups, respectively. Following 
drying off, cows were offered sufficient pasture and supplement to gain 0.5 BCS 
unit towards target calving BCS of 3.5, 4.5 and 5.5 at calving for the Low, 
Medium and High groups, respectively. Final mean BCS at calving were 3.4, 4.6 
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and 5.4 for the Low, Medium and High BCS groups, respectively. The mean BCS 
of each group over time is presented in Figure 20. 
Body condition score was determined by two experienced assessors twice per 
week (Monday and Thursday) following the morning milking or at an equivalent 
time during the non-lactating period. All BCS assessors were trained and 
recalibrated at the start of the experiment following the procedures set out by 
(Macdonald and Roche, 2004). The inter-observer variance component for BCS 
estimates was 0.05 (SD = 0.2). 
 
Figure 20. Mean body condition score (1 to 10 scale) of each group from selection in 
mid-lactation until 6 weeks post-calving. Data sourced from Roche et al. (2013c). 
During late lactation, daily feed allowances were adjusted to account for the 
average BCS state of the group and the proposed trajectory of BCS change. Cows 
in the High, Medium, and Low treatments had estimated daily DMI of fresh 
pasture of 12.3 (±3.38), 11.2 (±2.26), and 6.8 (±1.69) kg DM, respectively. 
Pasture and maize silage, and rolled maize grain, were provided to supplement 
DMI when sufficient pasture was not available. Allocated feed supplements were 
weighed, and estimations of wastage included in the final calculation of DMI 
from these sources. Cows in the Low group received 1.9 (±1.03) kg dry matter 
(DM) of pasture silage daily, those in the Medium group received 2.0 (±2.08) kg 
DM of pasture silage, 0.5 (±0.90) kg DM of maize silage, and 1.0 (±1.03) kg 
DM of rolled maize grain daily, and those in the High group received 2.4 (±2.04) 
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kg DM of pasture silage, 1.6 (±2.86) kg DM of maize silage, and 2.6 (±1.27) kg 
DM of rolled maize grain daily. When an individual cow‟s BCS was not tracking 
towards the treatment target, she was moved to a group with a feeding regime that 
facilitated the desired change. Groups grazed the same paddock with electric 
fences separating them. Mean pasture DMI was calculated as the product of the 
difference between the pre- and post-grazing pasture mass and area grazed on 
three d/wk, as outlined by Roche et al. (2005). 
General management of the cows, including mineral and trace element 
supplementation, was in accordance with research farm practice. From 30th May 
until calving, cows were supplemented with 10 g elemental Mg/cow per day via 
the water reticulation system (Dosatron Water Dispensers, Bell-Booth Ltd., 
Palmerston North, New Zealand)and received oral Mg supplement weekly as Mg 
pidolate (100 ml More-Mag, Dominion Chemicals (1988) Ltd., Auckland, New 
Zealand). Following calving, cows received oral Mg salts, sufficient to provide 20 
g elemental Mg/cow per day. 
On each day during calving, cows that had calved between 1000h the previous 
day and 1000h that day were brought to the farm dairy at 1300h (except where 
cows had observed calving difficulty (n = 2) or milk fever (n = 2), which were 
attended to immediately). Cows were milked twice a day. Cows entered a 
„colostrum herd‟ for their first 10 milkings, before being transferred to the 
„milking herd‟. From entry to the milking herd onward, the cows were managed 
as a single group and offered a generous feed allowance, with mean intakes of 
10.9 and 6.0 kgDM/cow/day, of pasture and pasture silage, respectively. 
Fifty-six cows completed the experiment: 20, 18, and 18, in the High, Medium, 
and Low groups, respectively. Results of the four cows that did not complete the 
sampling schedule were excluded from the analysis. One cow did not receive an 
immunisation on d0, one died of misadventure in autumn, another aborted her 
pregnancy, and the fourth developed aspiration pneumonia after calving and was 
euthanized. 
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 Immune testing protocol 7.2.2
Immune responses were measured during mid-lactation, to obtain baseline values 
before cows were allocated to their BCS treatment group, and immediately 
postpartum (d 0 was the day of calving). Cows were immunized intramuscularly, 
on d 0 and d 14, with type-1 (Candida albicans) and type-2 (hen egg white 
lysozyme, HEWL, or human serum albumin, HSA) antigens known to induce 
polarised CMIR and AMIR, respectively (Begley et al., 2009b, Cartwright et al., 
2012, Holland et al., 2001). The effect of calving BCS on AMIR was assessed 
using a cross-over design, with the type-2 antigen order crossed over within each 
level of BCS (Table 2) to permit assessment of both primary and secondary 
AMIR post-calving. Half of the cows in each BCS group were immunized with 
HEWL in mid-lactation and HSA postpartum (HEWL-HSA group); the remainder 
were immunized with HSA in mid-lactation and HEWL postpartum (HSA-HEWL 
group). The vaccine contained 0.5 mg of HEWL (L6876, Sigma Aldrich, 
Auckland, NZ) or 0.5 mg of HSA (A3782, Sigma Aldrich, Auckland, NZ), 0.5 mg 
C. albicans (CaWC, Greer Laboratories Inc, Lenoir, NC, USA) and 0.5 mg 
adjuvant (QuilA, Brenntag Biosector A/S, Frederikssund, Denmark) in 1mL 
sterile phosphate-buffered saline pH 7.4 (PBS). 
Table 2. Antibody-mediated immune function was assessed using a cross-over 
arrangement, with the type-2 antigen order crossed over within each body condition 
score treatment. Cows in the HEWL-HSA antigen treatment were immunized with 
HEWL in mid-lactation and HSA post-partum; cows in the HSA-HEWL treatment were 
immunized with HSA in mid-lactation and HEWL post-partum. The number of cows 
that completed the experiment in each group is presented in the table. 
 
Delayed-type hypersensitivity (DTH) reactions induced by the type 1 antigen 
were assessed, as an indicator of CMIR (Heriazon et al., 2011, Heriazon et al., 
 Low BCS  Med BCS  High BCS  
HEWL-HSA 10 11 9 
HSA-HEWL 10 8 8 
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2009b, Kobayashi et al., 2001). DTH reactions were induced on d 21 during 
baseline testing and d 8 during post-partum testing. Blood samples were collected 
by caudal venepuncture on d 0, 14, and 21 of each immune test. Serum was 
prepared after coagulation, by centrifugation (1500 x g for 10 min at 4°C) and 
stored at -20°C for later analysis of immunoglobulin content. 
 Evaluation of antibody-mediated immune response 7.2.3
Serum anti-HEWL specific IgG was measured using a previously described 
ELISA method (Begley et al., 2009a, Cartwright et al., 2011). Flat-bottomed 96-
well polystyrene plates (Nunc-Immuno
TM
 Plate, Maxisorp
TM
 surface, 
Thermofisher) were coated with HEWL dissolved in carbonate-bicarbonate buffer 
(1.44 mg/mL, pH 9.6, C3041, Sigma-aldrich) and incubated at 4°C for 24 h. 
Plates were washed three times with phosphate-buffered saline (PBS) containing 
0.05% Tween20 (wash buffer), using a Thermoscientific Wellwash Versa 
automatic plate-washer. Plates were then blocked with 200 μL per well of PBS 
(pH 7.4) containing 5 % Tween20 and 1 % gelatine (G7041, Sigma Aldrich) and 
incubated for 1 h at room temperature. Plates were again washed three times with 
wash buffer. Serum samples and controls diluted 1/400 and 1/1600 in wash buffer 
were added in quadruplicate (100μL per well), using a quadrant system (Wright. 
1987) and incubated at room temperature for 2 h. Negative and positive controls 
were a pooled sample of d 0 sera and a pooled sample of d 21 sera, respectively. 
Plates were washed five times, then 100 μL of alkaline phosphatase-conjugated 
sheep anti-bovine IgG (heavy chain specific, A10118AP, Bethyl Laboratories Inc, 
Montgomery, TX) diluted in Tris buffered saline (pH 7.4, T5912, Sigma Aldrich) 
containing 0.05% Tween20 was added to each well. Plates were incubated at 
room temperature for 1 h. Plates were washed a final five times then, the substrate 
p-Nitrophenyl phosphate disodium (p-NPP) in Tris buffered saline (pNPP 
substrate system, N2770, Sigma Aldrich) was added at 100 μL per well. Plates 
were incubated in the dark at room temperature and the optical density (OD) 
measured once OD of positive controls reached approximately 1.0. Optical 
density was measured with an ELISA plate reader (Thermoscientific Multiscan 
FO) at a wavelength of 405 nm. 
Antibody-mediated response to HSA was measured using a previously described 
ELISA method (Cartwright et al., 2012). Briefly, the ELISA protocol is as 
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described above for HEWL, except that plates were coated with 0.8mg/mL of 
HSA dissolved in carbonate-bicarbonate buffer, samples and controls were added 
at dilutions of 1/40 and 1/160. 
The ratio of IgG1 to IgG2-related antibodies produced in immune responses can 
provide an indication of type-1 or type-2 IR bias (Estes and Brown, 2002, Hine et 
al., 2011). Type-2 antigens (e.g. IL-4) promote production of IgG1 and type-1 
cytokines (e.g. IFN-γ) promote production of IgG2, therefore, IgG1 and IgG2 are 
considered to be type-2 and type-1 antibodies, respectively (Estes and Brown, 
2002). A balanced ability to mount both type-1 and type-2 responses is important 
for control of intra- and extra-cellular pathogens (Estes and Brown, 2002, Hine et 
al., 2011, Spellberg and Edwards, 2001). To assess type-1 or type-2 response bias, 
IgG1 and IgG2 antibody activity against HEWL and HSA were also determined in 
each serum sample by ELISA. The ELISA protocols used to determine antigen-
specific IgG1 and IgG2 to HEWL and HSA were similar to the respective 
protocols described above for IgGT with the following modifications: 
For anti-HEWL and anti-HSA IgG1, conjugated sheep anti-bovine IgG1 
(A10116AP, Bethyl Laboratories Inc, Montgomery, TX) was added. For anti-
HEWL and anti-HSA IgG1, conjugated sheep anti-bovine IgG2 (A10117AP, 
Bethyl Laboratories Inc, Montgomery, TX) was added. 
Any replicate OD greater than 20% above or below the median OD for the 
sample-dilution was excluded from analysis, as described by Stone et al (1991); 
0.4% of replicate ODs were removed for HEWL and 1.3% for HSA, with at least 
3 replicates analysed for all samples and controls at each dilution. CVs were 
calculated for the raw OD of the positive controls on each plate to determine 
whether plate results were accepted or rejected. Plates with a CV greater than 15% 
for positive control samples were reanalysed. CVs were calculated from the raw 
ODs for each sample, at both dilutions, to determine whether sample results were 
accepted or rejected. Samples with CV greater than 15% for either dilution were 
reanalysed on a subsequent plate. Inter-assay CVs using standardised data (as 
described below) were 2.2% and 2.0% for anti-HEWL and anti-HSA IgG, 
respectively. Intra-assay CVs, using standardised data, ranged from 3.6% to 4.6%. 
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To compare samples run across all plates, mean optical density values were 
corrected based on the mean OD value of the positive control sample run on the 
same plate, as a previously described (Hine et al., 2011, Mallard et al., 1997). For 
each plate, the mean OD of the blank wells were subtracted from the mean OD of 
all sample and control replicates And replicates were standardized using the 
positive control at the same dilution on the plate as described above. Briefly, the 
mean OD of the positive control on each plate was corrected to an OD of 1.0, and 
all mean test values on the same plate were corrected by the same factor (the 
inverse of the mean positive control). Corrected means for each test serum 
dilution were then added together to give an additive OD value for each test 
sample, and these values were used for statistical analysis. 
 Evaluation of cell-mediated immune response 7.2.4
Cutaneous DTH to C. albicans was measured, following previously described 
protocols (Hernández et al., 2005, Hine et al., 2011, McGowan et al., 2014).   
Intradermal injections of 0.1 mg CaWC in 0.1ml PBS (test) and 0.1 ml PBS 
(control) were each administered to an opposing caudal skin-fold of the tail. All 
intradermal injections were administered with a 29 g needle/insulin syringe 
(Terumo, Shoof International, Cambridge, New Zealand). The site of each 
injection was marked with correction fluid (twink) to allow subsequent 
measurements at the same site. The double skin-fold thickness (DSFT) at each 
injection site was measured (3 repetitions) using a Harpenden spring-loaded dial-
calliper (Mentone Educational Centre, Victoria, Australia), immediately before 
injection and at both 24 and 48 hours after injection. Pilot studies of DTH testing 
with CaWC in grazing cows had demonstrated that the time to maximal response 
varied between individual cows, with similar numbers having maximal responses 
at both time points (McGowan et al., 2014). 
Relative increases in DSFT were calculated at both 24 and 48 h post-injection and 
expressed as the change in log of DSFT at test site / DSFT at control site, from 0 
h, as described by Hine et al. (2011): 
Response = log (Th/Ch) – log (T0/C0) 
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Where Th = mean test DSFT at time h; T0 = mean test DSFT at 0 h; Ch = mean 
control DSFT at time h; C0 = mean control DSFT at 0 h; and time h was 24 or 48 
h.  
 Colostrum antibody 7.2.5
A pooled colostrum sample was collected from each cow before her first milking 
and stored at -20°C for later analysis. Colostrum samples were analysed in 
duplicate for their immunoglobulin content (mg/ml) by colorimetric ELISA 
methods using commercial kits (Bethyl Laboratories, Inc., Montgomery, TX). 
These assays had been demonstrated by the manufacturer to be highly specific for 
each respective immunoglobulin isotype in bovine samples by 
immunoelectrophoresis and ELISA methods. Dilution rates for samples varied 
between 1:20000 and 1:40000 for IgA, 1:40000 for IgM, 1:600000 and 1:800000 
for IgG1, and 1:10000 to 1:30000 for IgG2. Inter-assay CV‟s were 21%, 19%, 
15% and 25% for IgG1, IgG2, IgM and IgA, respectively.  
 Statistical Analyses 7.2.6
Statistical analyses were undertaken to assess AMIR and CMIR. Specific 
antibody responses were examined based on the OD value at each time point and 
the area under the curve between time points. The primary response was 
determined using the concentration of IgG on d 14 and the secondary response 
was evaluated as the concentration of IgG on d 21. Delayed-type hypersensitivity 
(CMIR) was evaluated at 24 and 48 h post intradermal injection. An increase in 
DSFT of >1 mm from 0 h was considered a positive DTH response and an 
increase in OD of >0.1 induced by immunisation was considered a positive AMIR 
response, as per Hine et al (2011).  
Observations were log10-transformed to ensure normalisation of the residuals. The 
transformed data satisfied the assumptions of ANOVA and were used to calculate 
P-values. However, the corresponding least squares means and standard errors of 
the non-transformed data are presented in the results for clarity. 
Results from mid-lactation were analysed separately from those at calving. For 
mid-lactation, responses (raw and differences from baseline; dfb) were analysed 
using mixed models approach to repeated measures (Proc Mixed, SAS 9.3) with 
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time, antigen, and their interactions included as fixed effect and cow as random 
effect. Area under the curve (AUC) based on dfb were analysed using two-way 
analysis of variance (ANOVA) for the effect of antigen. For post-calving, 
responses (raw and dfb) were analysed using mixed models approach to repeated 
measures (Proc Mixed, SAS 9.3) with time, antigen, BCS, and their interactions 
included as fixed effect and cow as random effect. AUC based on difference from 
baseline were analysed using two-way ANOVA for the effects of antigen, BCS, 
and their interaction. The individual response in mid-lactation was accounted for 
when assessing responses post-calving by including AUC from mid-lactation as a 
covariate. To estimate the stage of lactation effect (mid-lactation to calving), a 
repeated measures analysis of AUC for IgG and DTH, and of raw data for 
IgG1:IgG2 was conducted (Proc Mixed, SAS 9.3), with antigen, BCS and stage of 
lactation included as fixed effects and cow as random effect. Tukey‟s test was 
used for pairwise comparisons. Results are presented as least-squares means and 
standard errors. Significance is declared if P < 0.05). 
One outlier, in the Med BCS group, was removed from the analysis of IgG1:IgG2 
ratio because the magnitude of her IgG1:1gG2 ratio was 4-5 times greater than the 
other cows on d0 and d14 and consequently changed the response patterns and 
outcomes for IgG1:IgG2 ratio to an unacceptable degree. The IgGT, IgG1, IgG2 
and DTH responses for this cow were within the normal range and inclusion or 
exclusion of this cow did not affect the relationship between calving BCS and 
those immune measures, therefore she was not excluded from other analyses. 
7.3 Results  
 Mid-lactation immune responses 7.3.1
Antigen-specific IgG responses to immunisation with HEWL or HSA in mid-
lactation are presented in Figure 21. There was a significant interaction between 
antigen type and time (P < 0.05). Primary immunisation with HEWL did not 
significantly increase IgG antibody concentrations at d14 (P = 0.20); whereas, 
primary immunisation with HSA increased IgG concentrations at d14 (P < 0.001). 
Secondary immunisation with either HEWL or HSA increased IgG concentrations 
at d21 relative to d14 (P < 0.001) in 100% of cows. The AUC of IgG was not 
affected by antigen type (P = 1). 
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Figure 21. Least-squares means and SE of antigen-specific IgG antibody response of 
moderately producing pasture-fed cows in mid-lactation, to immunisation with hen 
eggwhite lysozyme  or human serum albumin  , on d 0 and 14. Responses 
expressed as change in the log of optical density (OD) value from d0, measured at d 14 
and 21. 
 
Figure 22. Least-squares means and SE of antigen-specific IgG1:IgG2 ratio of antibody 
responses, in moderately producing pasture-fed cows in mid-lactation, to immunisation 
with hen eggwhite lysozyme  or human serum albumin  , on d 0 and 14. Data 
presented are IgG1:IgG2 ratio, relative to d 0. 
Overall, the IgG1:IgG2 ratio increased from d14 to d21 following immunisation 
with type-2 antigen (0.45 ± 0.21, P < 0.05, Figure 22); however, the difference 
between IgG1:IgG2 on d14 and d21 was not significant for HEWL (0.24 ± 0.86, P 
= 0.86) or HSA (0.66 ± 0.31, P = 0.16). 
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Delayed-type hypersensitivity responses to C. albicans in mid-lactation are 
presented in Figure 23. Positive DTH responses were evident in 100% of cows. 
Responses at 24 and 48 hours were larger than at 0 hours (P < 0.001), but did not 
differ between 24 and 48 hours (P = 0.90). The type-2 antigen included in the 
immunisation protocol (HEWL or HSA) did not affect the subsequent DTH 
response to C. albicans (P = 0.66). 
Figure 23. Least-squares means and SE of delayed-type hypersensitivity responses of 
moderately producing pasture-fed cows in mid-lactation, to C. albicans whole cell co-
immunized with either hen eggwhite lysozyme  or human serum albumin  , on d 0 
and 14. Responses expressed as change in the log of test site / control site from 0 h, 
measured at 24 and 48 h post–injection. 
 Effect of calving on immune responses 7.3.2
Antibody-mediated immune responses were smaller at calving than in mid-
lactation; whereas, cell-mediated immune responses were larger. Positive antigen-
specific IgG responses were evident in 90% and 96% of cows immunised with 
HEWL and HSA, respectively. Mean AUC of antigen-specific IgG, IgG1 and 
IgG2 responses were lower at calving than in mid-lactation (P < 0.01, Table 3). 
There was a significant increase in IgG1:IgG2 ratio from d14 to d21 post-calving 
(0.99 ± 0.16, P < 0.001) and that increase was larger than the increase recorded in 
mid-lactation (Figure 24). Positive DTH responses were evident in 100% of cows. 
The magnitude of DTH responses was bigger at calving than in mid-lactation (P < 
0.001, Table 3).  
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Table 3. Difference in magnitude of adaptive immune responses measured at calving 
compared with responses measured in mid-lactation, in moderate producing pasture-fed 
dairy cows. Results presented are the difference in the response area under curve, for 
calving compared with mid-lactation. 
 Difference LSM Std Error Adjusted P-value % change 
IgG -2.7 0.85 <0.01 - 31 
IgG1 -2.4 0.80 <0.01 - 28 
IgG2 -3.8 1.14 <0.01 - 51 
DTH 1.9 0.39 <0.001 + 38 
 
 
Figure 24. Least-squares means and SE of antigen-specific IgG1:IgG2 ratio of antibody 
responses to type-2 antigen, in pasture-fed dairy cows in mid-lactation  and at calving 
 . 
Cows that produced large adaptive immune responses in mid-lactation generally 
produced large responses postpartum. There was a significant effect of mid-
lactation AUC for DTH, IgG, and IgG1 response on the AUC of equivalent 
measurements postpartum (P < 0.01, P < 0.05, and P < 0.01, respectively; Table 
4). However, there was no effect of mid-lactation values on AUC for IgG2 on 
IgG2 at calving (P = 0.16; Table 4). 
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Table 4. Probabilities for the effects of mid-lactation response magnitude, type-2 antigen, and BCS on immune responses at calving in mixed aged dairy 
cows. 
Antigen-
specific 
response 
variable 
mid-
lactation 
AUC 
type-2 
Antigen 
BCS 
Antigen X 
BCS 
Time (day or 
hour) 
BCS X time 
Antigen X 
time 
IgG raw dfb < 0.01 0.37 0.93 0.78 < 0.0001 0.67 0.36 
  AUC dfb 0.0175 0.097 0.9333 0.6086 NA NA NA 
IgG1 raw dfb < 0.001 0.16 0.84 0.74 < 0.0001 0.68 0.99 
 
AUC dfb < 0.005 < 0.05 0.94 0.66 NA NA NA 
IgG2 raw dfb 0.21 < 0.05 0.79 0.34 < 0.0001 0.13 < 0.0001 
  AUC dfb 0.16 0.18 0.81 0.41 NA NA NA 
IgG1:IgG2 raw dfb 0.94 0.12 0.49 0.49 0.12 0.36 0.95 
 
AUC dfb NA NA NA NA NA NA NA 
DTH raw dfb < 0.005 0.18 0.95 0.07 < 0.0001 0.54 0.36 
  AUC dfb < 0.005 0.13 0.99 < 0.05 NA NA NA 
AUC = area under curve; dfb = difference from baseline (day 0 or hour 0); type-2 Antigen = HEWL/HSA; BCS = body condition score at 
calving.
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 Effect of BCS on immune responses at calving 7.3.3
Postpartum antigen-specific IgG responses to immunisation with a type-2 antigen 
are presented in Figure 25. There were no significant effects of BCS at calving on 
circulating concentrations of antigen-specific IgG (P = 0.93; Figure 25), IgG1 (P 
= 0.95; Figure 26), or IgG2 (P = 0.81; Figure 27), and no interactions between 
BCS and day, or BCS and antigen for IgG, IgG1 or IgG2 concentration (Table 4). 
There was also no significant effect of BCS on the IgG1:IgG2 ratio (P = 0.48; 
Figure 28), and no interaction between BCS and day or BCS and antigen for 
IgG1:IgG2 ratio (Table 4). 
 
Figure 25. Least-squares means and SE of antigen-specific IgG antibody response to 
immunisation with type-2 antigen on d 0 and 14, in dairy cows with body condition score 
3.4   , 4.6   and 5.4   at calving (1-10 BCS scale, where 1 is emaciated and 10 obese; Roche 
et al., 2004). Responses expressed as change in the log of optical density (OD) value from 
d0, measured at d 14 and 21. 
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Figure 26. Least-squares means and SE of antigen-specific IgG1 antibody response to 
immunisation with type-2 antigen on d 0 and 14, in dairy cows with body condition score 
3.4  , 4.6  and 5.4  at calving 1-10 BCS scale, where 1 is emaciated and 10 obese; 
Roche et al., 2004). Responses expressed as change in the log of optical density (OD) 
value from d0, measured at d 14 and 21. 
 
Figure 27. Least-squares means and SE of antigen-specific IgG1 antibody response to 
immunisation with type-2 antigen on d 0 and 14, in dairy cows with body condition score 
3.4  , 4.6  and 5.4  at calving 1-10 BCS scale, where 1 is emaciated and 10 obese; 
Roche et al., 2004). Responses expressed as change in the log of optical density (OD) 
value from d0, measured at d 14 and 21. 
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Figure 28. Least-squares means and SE of antigen-specific IgG1:IgG2 ratio of antibody 
response to immunisation with type-2 antigen on d 0 and 14, in dairy cows with body 
condition score 3.4  , 4.6  and 5.4  at calving 1-10 BCS scale, where 1 is emaciated 
and 10 obese; Roche et al., 2004). Responses expressed as change in the log of optical 
density (OD) value from d0, measured at d 14 and 21.  
 
Figure 29. Least-squares means and SE of delayed-type hypersensitivity responses to C. 
albicans whole cell, in dairy cows with body condition score 3.4  , 4.6  and 5.4  at 
calving (1-10 BCS scale, where 1 is emaciated and 10 obese; Roche et al., 2004). 
Responses expressed as change in the log of test site / control site from 0 h, measured at 
24 and 48 h post–injection. 
Postpartum DTH responses to C.albicans are presented in Figure 29. Body 
condition score at calving did not affect the AUC of DTH responses (P = 0.99). 
0.0
0.5
1.0
1.5
2.0
2.5
14 21
C
h
an
ge
 in
 Ig
G
1
:I
gG
2
 f
ro
m
 d
ay
 0
 
day 
 83 
 
However, there was an interaction between antigen type (co-administered type-2 
antigen) and BCS on the DTH response (P < 0.05; Table 4), with the AUC of 
DTH responses for cows co-immunized with HSA at calving higher than for cows 
immunized with HEWL at calving for high and medium BCS cows, but not low 
BCS cows. There were no other interactions between BCS, antigen or time on 
DTH response. 
Concentrations of total IgA, IgM, IgG1, and IgG2, and the ratio IgG1:IgG2 in 
colostrum are presented in Table 5. Cows in the Low BCS group had lower IgM 
concentration in colostrum (P < 0.05), whereas concentrations of IgA, IgG1 and 
IgG2 were similar for all BCS treatments (P = 0.23, P =0.85 and P =0.69, 
respectively).  
Table 5. Mean immunoglobulin concentrations (mg/ml) in colostrum samples taken at 
the first milking for cows in the High, Medium and Low treatments. Shared letters 
indicate no significant difference. 
 High Medium Low sed P 
n 20 18 18   
IgA 7.9 9.7 7.3 1.37 0.23 
IgM 8.5 ab 10.6 a 7.3 b 1.30 <0.05 
IgG1 43.0 43.1 45.8 5.53 0.85 
IgG2 3.3 2.9 3.0 0.52 0.69 
7.4 Discussion  
The objectives of this study were to determine the effect of BCS at calving on 
post-partum immune function in pasture-fed cows, measured by assessing CMIR 
to type-1 antigen (C. albicans) and AMIR to type-2 antigens (HEWL and HSA). 
To our knowledge, this is the first in vivo investigation of postpartum adaptive 
immune responses in pasture-fed dairy cows with imposed differences in BCS at 
calving. The energy balance of healthy cows was manipulated in mid- and late 
gestation to generate groups differing in BCS at calving. We hypothesized that 
both CMIR and AMIR would be suppressed postpartum, and that cows with 
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higher BCS at calving would have a greater NEB in early lactation, and as a 
result, would have reduced AMIR and CMIR and increased type-2 immune 
response bias relative to cows with lower BCS at calving.. 
 Immune function at calving 7.4.1
The presented results support the paradigm of immune dysfunction in the 
peripartum cow but do not support the hypothesis of a suppression of both CMIR 
and AMIR post-partum. Antibody-mediated responses were markedly impaired 
postpartum, as evidenced by a 31% reduction in the mean AUC of the IgG 
response to an antigen challenge. In contrast, the mean magnitudes of the DTH 
responses were 38% greater during the postpartum period than in mid-lactation. 
Suppressed AMIR is consistent with previous research, in which it was reported 
that peripartum dairy cows have lower B-lymphocyte proliferation and antibody 
production in vitro compared with cows at other stages of lactation (Lacetera et 
al., 2005, Nagahata et al., 1992, Nonnecke et al., 2003). Unlike AMIR, which is 
consistently reported to be impaired postpartum, previous reports of CMIR in 
peripartum dairy cows have been mixed. Interferon- is the central cytokine 
involved in development of DTH (Nonnecke et al., 2003, Young and Hardy, 
1995). Lacetera et al. (2005) reported that mean in vitro IFN- secretion did not 
decrease postpartum; whereas, Ishikawa et al. (1994) and Nonnecke et al. (2003) 
reported reduced ability of stimulated T-lymphocytes to secrete IFN- in the early 
postpartum period  The increased magnitude of postpartum DTH reported here 
may be largely attributed to additional priming induced by the immunisation on 
day of calving. Nevertheless, increased DTH magnitude indicates that lymphocyte 
secretion of IFN- and recruitment of macrophages and neutrophils is not 
impaired postpartum. Our results provide further evidence of impaired AMIR in 
peripartum cows, consistent with previous studies, but indicate, at least for the 
cows in this study, that the changes in CMIR are less severe than implicated in 
previous in vitro studies. 
In addition to the reduced AMIR magnitude, the results indicate a type-2 shift in 
immune responses, meaning postpartum AMIR was biased toward anti-
inflammatory mechanisms. The increase in IgG1:IgG2 ratio from d14 to d21 was 
larger post-calving, relative to mid-lactation AMIR responses. The ratio 
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IgG1:IgG2 indicates the relative balance of type-1 and type-2 mechanisms in an 
immune response, with higher values indicative of a response that is more biased 
toward type-2 immune response mechanisms (Estes and Brown, 2002, Hine et al., 
2011). Type-2 responses promote a higher rate of IgG1 production, relative to 
IgG2 production; therefore, an increase in IgG1:IgG2 ratio indicates that post-
calving AMIR had a stronger type-2 bias than AMIR in mid-lactation. This type-2 
shift is consistent with Shafer-Weaver et al. (1999) and Shafer-Weaver and 
Sordillo (1997), who reported a type-2 shift peripartum, as evidenced by a higher 
ratio of IL4:IFN- cytokine secretion in T-lymphocytes isolated from peripartum 
cows than in T-lymphocytes isolated at other times.   Most infections, with the 
exception of large eukaryotes, are controlled by type-1 mechanisms before a shift 
to type-2 mechanisms resolves the response (Spellberg and Edwards, 2001), 
therefore, the apparent type-2 bias postpartum may lead to inadequate cellular 
defences against infection. 
 Effect of BCS on measures of immune function  7.4.2
Body condition score at calving did not influence adaptive immune 
responsiveness or the balance between type-1 and type-2 immune response in 
healthy cows and within the range of BCS investigated. Evidence for this includes 
the lack of effect of BCS on DTH responses and on the production of antigen-
specific IgG2 antibodies (reflecting type-1 immune responses) and on the 
production of antigen-specific IgG1 concentrations (reflecting type-2 responses). 
The ratio of IgG1:IgG2, for which higher values indicate response biased toward 
type-2 mechanisms (Estes and Brown, 2002, Hine et al., 2011), also did not differ 
between BCS groups. These results are not consistent with those of Lacetera et al. 
(2005), who reported peripartum impairment of both type-1 and type-2 
lymphocyte functions increased as calving BCS increased. The BCS range 
included in this experiment was narrower than that studied by Lacetera et al. 
(2005; approximately BCS 3.0 to 7.5 on the 10 point scale: Roche et al., 2004). 
However, the range of NEFA concentrations reported by Lacetera et al. (2005) 
were similar to those reported in the cows investigated here (Roche et al., 2013c). 
The range of NEFA concentrations reported by Lacetera et al. (2005) for the first 
week of lactation was approximately 0.55, 0.7 and 1.0 mmol/L for BCS 3.0, 5.5 
and 7.5, respectively. Roche et al. (2013c) reported mean NEFA concentrations 
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for the cows investigated here, of 0.48, 0.71 and 0.93 mmol/L for BCS 3.4, 4.6 
and 5.4, respectively, for the first 6 weeks of lactation. 
Ohtsuka et al. (2008) reported that type-2 bias increased with greater postpartum 
loss of BWT. In the current experiment, cows that calved at higher BCS lost more 
BWT postpartum and had higher blood NEFA than cows with lower calving BCS 
(Roche et al., 2013c), but there was no significant difference in the IgG1:IgG2 
ratio between the groups. Ohtsuka et al. (2008) and Lacetera et al. (2005) both 
measured the function of isolated lymphocytes in vitro. This may not reflect 
function in vivo, where other immune cells and proteins contribute to the immune 
response (Sander et al., 2011). Although the BCS range investigated here was 
narrower than previous investigations, it reflected the range of calving BCS 
evident in New Zealand dairy herds. Our results indicate that, for cows calving 
within the BCS range investigated, BCS at calving and the associated degree of 
postpartum NEB did not influence ability to mount an effective adaptive immune 
response in vivo. 
Calving BCS did not influence colostrum quality. Although the concentration of 
IgM in colostrum was lower in the Low BCS group, the difference was small, and 
concentration of IgG1, IgG2 and IgA did not differ between BCS groups. IgG1 is 
selectively transported to the mammary gland during colostrogenesis and is the 
most important antibody in colostrum, being present in much greater 
concentration than other isotypes and more protective against rotavirus (Franklin 
et al., 2005, Mallard et al., 1998, Sasaki et al., 1976). Therefore, from the 
perspective of passive transfer of immunity to the calf, BCS at calving did not 
affect colostrum quality.  
 The role of negative energy balance in immune dysfunction 7.4.3
These and other results indicate that the severity of postpartum NEB is not the 
primary contributor to peripartum immune dysfunction. The BCS treatment 
imposed in this experiment generated three groups with very different degrees of 
postpartum NEB but the groups did not differ in the magnitude of AMIR or 
CMIR, or in their bias towards type 1 or type 2 responses. The difference and 
range of serum NEFA concentrations in early lactation was comparable in this 
study (Roche et al., 2013c) to those reported in previous investigations of 
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periparturient immune function (Goff et al., 2002, Lacetera et al., 2005, Ster et al., 
2012). Increased adipose mobilisation and elevated serum NEFA and BHBA 
concentrations have been associated with retained placenta, metritis and mastitis 
(Holtenius et al., 2004, Kaneene et al., 1997, Ospina et al., 2010), and with 
impaired lymphocyte and neutrophil function (Grinberg et al., 2008, Lacetera et 
al., 2004, Ster et al., 2012). However, the association between measures of NEB 
and immune dysfunction has been inconsistent. Nonnecke et al. (1992) reported 
that in vitro secretion by lymphocytes was not affected by physiologically 
relevant levels of glucose, ketones and acetate. Similarly, elevated NEFA and 
BHBA in later lactation, as a result of dietary-induced NEB, is reported to have 
inconsistent or negligible effect on immune function (Ingvartsen and Moyes, 
2013, Moyes et al., 2009a), and has even been reported to stimulate phagocytosis 
and production of both type-1 and type-2 cytokines (Ingvartsen and Moyes, 
2013). Recent work, using whole-blood assays to measure neutrophil function and 
number during the transition period, reported increased rather than decreased 
capacity for phagocytosis postpartum, with no clear relationship between 
phagocytic power and serum NEFA and BHBA concentrations (Sander et al., 
2011). This finding, which differs from reports using isolated neutrophils, was 
attributed to the presence of opsonising factors in whole blood that are not present 
in a purified preparation (Sander et al., 2011). Previous investigations of the 
relationship between BCS or NEB on lymphocyte function have mostly been in 
vitro using purified cell preparations. The differences between the results reported 
here and those of Lacetera et al. (2005) indicate that the function of isolated 
lymphocytes in vitro may not reflect function in vivo, where other immune cells 
and proteins contribute to the immune response (Sander et al., 2011). Our results 
indicate that, for cows calving within the range of BCS investigated, ability to 
mount an effective adaptive immune response in vivo was not influenced by the 
degree of postpartum NEB. 
 The role of hypocalcaemia in immune dysfunction 7.4.4
Low serum concentration of calcium has previously been associated with 
impaired lymphocyte function, possibly because calcium plays critical role in 
activation and function of immune cells (Kimura et al., 2006); the results of this 
experiment do not contradict nor confirm this association. The serum 
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concentration of calcium, did not differ between BCS groups on the day of 
calving or during the first 6 weeks of lactation (Roche et al., 2013c). Serum 
calcium in the first week of lactation was within the normal range for healthy 
cows (Roche et al., 2013c), and higher than reported for mastectomised and intact 
cows on the day of calving (Goff et al., 2002, Kimura et al., 2006). Although there 
was no apparent relationship between BCS and either serum calcium 
concentration in early lactation or adaptive immune responsiveness during this 
time, possible links between serum calcium and peripartum immune dysfunction 
cannot be excluded. 
 The role of negative protein balance in immune 7.4.5
dysfunction 
Dietary protein deficiency has been reported to suppress adaptive immunity (Dai 
and McMurray, 1998), because protein is required for the proliferation of 
lymphocytes and secretion of cytokines and immunoglobulins. Cows in the Low 
BCS group had lower protein stores and were in a greater negative protein balance 
during early lactation (reported in Roche et al 2013); however, the view of the 
authors was that, although milk production was reduced, other functions, such as 
the cows‟ ability to mount an acute phase response, were not compromised. The 
results reported here support the premise of Roche et al. (2013c), that the negative 
protein balance observed in the low BCS cows peripartum was not sufficient to 
impair immune function to a greater degree than was observed in the other BCS 
groups. 
7.5 Conclusion 
Under the conditions of this experiment, and the range of BCS tested, BCS at 
calving did not significantly affect the ability of cows to mount an adaptive 
immune response. Neither elevated NEB in high BCS cows nor low protein 
balance in low BCS cows postpartum appeared to affect cows‟ ability to mount 
AMIR and CMIR. Periparturient immune dysfunction was evident, with reduced 
AMIR and increased type-2 bias of AMIR postpartum relative to mid-lactation.   
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Chapter 8. General discussion 
In this thesis, I set out to directly investigate the relationship between calving BCS 
and adaptive immune function in early lactation, using in vivo measures that have 
been associated with incidence of clinical diseases, such as mastitis and metritis. 
Here I discuss several key points arising from this study, comment on the 
implications and suggest where future research should focus. 
Cows in a New Zealand pasture-based herd had low background sensitivity 
to Candida albicans. 
I established the use of two in vivo measures of adaptive immune function in New 
Zealand pasture-based dairy cows. In the first experiment (Chapter 6), I reported 
low background DTH responses to C. albicans, in a New Zealand pasture-based 
herd. Although this test had been used extensively in North American and Irish 
dairy herds, the only reported investigation of background DTH responses was in 
a housed system (Heriazon et al., 2009a), which may have a different level of 
exposure to C. albicans than a pasture-based system. Having confirmed low 
background DTH in the Lye farm herd, I could confidently use DTH reactions to 
C. albicans as a measure of CMIR in the second experiment. 
For the second experiment (Chapter 7), I used change in antigen-specific antibody 
concentrations after immunisation with type-2 antigens (HEWL and HSA) as a 
measure of AMIR, in addition to using DTH as a measure of CMIR. These tests 
provide a low impact assessment of immune function, without causing a clinical 
disease that would require antibiotic or other therapy to resolve. Previous in vivo 
measures have largely been limited to infectious challenges, such as 
intramammary infusion of mastitis bacteria to induce clinical mastitis; these 
challenges can have a large impact on the productivity and welfare of cows 
enrolled in those experiments. This is the first study that I am aware of to use low 
impact, in vivo measures of adaptive immune function and imposed calving BCS 
to investigate the relationship between calving BCS and immune function in 
pasture-based dairy cows. 
Although adaptive responses were assessed here, these responses depend on 
innate function for activation so they may also act as de-facto measures of innate 
immune function. High responses on these tests have been associated with lower 
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incidence of several diseases usually thought to be primarily controlled by the 
innate immune system (Thompson-Crispi et al., 2013). Low CMIR has been 
associated with lower expression of IL-8 (Nino-Soto et al., 2008), which 
contributes to increased RFM and increased metritis in low CMIR cows 
(Thompson-Crispi et al., 2012). Cows with low AMIR responses have also been 
reported to have increased incidence of metritis (Thompson-Crispi et al., 2012). It 
would be interesting to investigate if, when adaptive immune function is impaired, 
whether that impairment is mediated by innate functions, such as reduced 
macrophage secretion of IL-8, or whether it can be wholly attributed to altered 
lymphocyte function. 
Body condition score at calving did not affect adaptive immune responses. 
There is a perception that thin cows are less healthy than fatter cows and, on this 
basis, are of welfare concern. The research undertaken in the compilation of this 
thesis indicates no relationship between BCS at calving and adaptive immune 
function. It could be argued that a wider BCS range would need to be investigated 
to completely rule out a relationship between calving BCS and early lactation 
adaptive immune function. However, the BCS range investigated here represented 
very thin to moderately conditioned cows and reflected the range of calving BCS 
evident in New Zealand dairy herds. At the very least, the research results support 
the lower allowable BCS of 3.0 that has been mandated in the New Zealand Code 
of Welfare for Dairy Cattle (Code of Welfare: Dairy Cattle 2014). 
The extent of early lactation NEB, and associated serum NEFA, was not 
related to adaptive immune responses. 
Despite the welfare concerns for low BCS cows, high BCS cows lose more BCS 
in early lactation and this greater NEB may pre-dispose them to a greater risk of 
disease. It had previously been reported that impairment of in vitro IgM and IFN- 
γ responses is proportional to BCS loss (Lacetera et al., 2005) and incubation of 
lymphocytes in high concentrations of NEFA and ketones reduces antibody 
responses (Lacetera et al., 2004, Wentink et al., 1997) and production of pro-
inflammatory cytokines (Franklin et al., 1991, Lacetera et al., 2004, Sato et al., 
1995, Ster et al., 2012, Suriyasathaporn et al., 1999, Suriyasathaporn et al., 2000). 
However, in this study, despite greater loss of BCS and higher serum NEFA 
concentrations in early lactation (Roche et al., 2013c), cows with high calving 
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BCS did not exhibit greater immune dysfunction than cows with lower calving 
BCS. Therefore other factors may be responsible for the increased immune 
dysfunction in over-conditioned dairy cows reported in previous studies. 
On the basis of this research, there is no cause for changing the recommended 
calving BCS for mature cows or the minimum BCS allowed by the welfare code. 
However, the cows in this experiment were very well managed and were well fed 
pre- and post-calving. The level of energy intake pre-calving is reported to affect 
postpartum NEB, systemic inflammation and neutrophil function (Graugnard et 
al., 2012). Reduced DMI in the weeks preceding calving increases the risk of 
metritis and retained fetal membranes (Huzzey et al., 2007, LeBlanc, 2008) and 
low CMIR has also been associated with increased RFM and increased metritis 
(Thompson-Crispi et al., 2012). Therefore, an interesting follow up experiment to 
the current work would be to investigate the interaction between calving BCS and 
feeding level pre- and post-calving on adaptive immune function. 
Periparturient immune dysfunction was apparent in antibody-mediated 
responses but not cell-mediated immune responses. 
In Chapter 7, I was able to evaluate the effect of calving on the immune system‟s 
ability to respond to a prescribed antigen by comparing the CMIR and AMIR 
responses in mid-lactation with those immediately post-calving. My results reflect 
a dysfunctional immune system consistent with previous research. Although cell-
mediated immune responses did not appear to be impaired at calving; in fact, the 
magnitude of DTH responses was increased by 38%, this increase can possibly be 
attributed to the additional priming provided by immunisation at calving. In 
contrast, AMIR responses to type-2 antigens were reduced by 31%. The majority 
of mastitis pathogens are extracellular; therefore, lower AMIR in early lactation 
likely contributes to increased incidence of clinical mastitis, as reported in 
Canadian herds by Wagter et al. (2000) and Thompson-Crispi et al. (2013). The 
reduction in AMIR is also consistent with the relaxation of immunity to 
nematodes reported in many species during late gestation and early lactation  
(Barger and Gibbs, 1981, Houdijk, 2008, Kloosterman et al., 1985), although, 
there was no effect of BCS on immunity like that reported in sheep, which have 
lower worm burdens if they have greater adipose reserves in late gestation 
(Valderrábano et al., 2006, Valderrábano and Uriarte, 2003). The difference 
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between my results and those reported in sheep may be due to the equalising 
effect of NEB, which is more extensive in dairy cows than in sheep: while high 
BCS cows have greater reserves, NEB induces a reduction in leptin such that the 
perceived availability of energy would be similar between low and high BCS 
cows in early lactation (Kokkonen et al., 2005). 
Maintenance of CMIR, while AMIR is decreased, is opposite to what is expected 
during NEB. The physiological state of a transition cow has been likened to that 
of humans and rodents undergoing severe protein-energy malnutrition (Goff, 
2008); however, in protein-energy malnutrition, CMIR is the most impaired 
response and AMIR is either maintained or elevated (Abrams and Miller, 2011). 
Decreased leptin, as occurs during negative energy balance or when adipose 
reserves are limited, usually leads to a decrease in CMIR. However, leptin acts on 
naïve T-lymphocytes rather than memory T-lymphocytes (Lord et al., 1998). 
Therefore, in experiment two, reduced leptin in early lactation may have reduced 
AMIR because the antigen was novel, whereas CMIR was unaffected because the 
cows had already been exposed to C. albicans in mid-lactation and already had 
memory T-lymphocytes for C. albicans. Consequently, the DTH response may 
have been able to proceed without the requirement for leptin to support activation 
of naïve T-lymphocytes. Future research could investigate the role of leptin in 
secondary AMIR and CMIR responses. 
Concluding remarks 
This study offers convincing evidence that BCS at calving, and the associated 
degree of NEB does not affect adaptive immune function in early lactation. Cows 
calving within the BCS range examined (between 3.5 and 5.5) did not differ in 
AMIR or CMIR; therefore, the results support the current recommendations 
regarding optimal calving BCS for mature cows, and support the minimum BCS 
standards allowed by the welfare code. An investigation of the interaction 
between calving BCS and feeding level during the transition period would 
confirm whether or not the lack of BCS effect reported here is influenced by 
feeding level.  
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